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1. Introduction 
1. Introduction 
Grundforskning är vad jag gör när jag inte vet vad jag gör 
The complexity of the mammalian brain and sensory organs is immense. In no 
other system is the signalling within and between cells so poorly understood. This 
signalling, or neurotransmission, is based on substances that, upon release from nerve 
terminals, act on receptor sites at postsynaptic membranes to produce either excitation 
or inhibition of the target cell. Often endogenously produced neuroactive substances, 
neurotransmitters like catecholamines, amino acids, peptides, and proteins, are present 
in picomolar to millimolar intracellular concentrations, resulting in extracellular levels 
at the femtomolar to micromolar range. In order to monitor the small amounts of 
biomolecules in small volumes, and to detect minor changes in these trace levels, 
sensitive and selective analytical methods need to be developed. 
The application of different chromatographic techniques1 began with the work of 
Runge in 1850 . He observed that certain coloured substances when spotted onto a 
filter paper spread out into concentric rings. Afterwards Rounge, Schönbein in 18613, 
and his student Goppelsröder4, together developed the capillary analysis based upon 
the height to which the various components are sucked up by a filter paper. However, 
modern chromatography as we know it today was first presented by Tsvett in 19065, 
resulting in the development of paper-, thin-layer-, gas- and liquid chromatography. 
These techniques have contributed to structural and fiintional data on many new 
biomolecules during the last century. 
Due to the heterogeneity of cell types in the nervous system, it would be ideal to 
have methods that allow studies of these biomolecules at the single cell level. The 
analysis of neurotransmitters both at the single cell level, and in tissue samples 
comprised of various preparations of cells from the nervous system is an area of great 
importance, where capillary electrophoresis (CE) has emerged as a powerful tool. This 
has been the subject of recent reviews6, 1. Briefly, CE has been employed in the 
g 
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analysis of neuroactive substances (i.e. proteins, neuropeptides, amino acids, 
catecholamines, thiols and polyamines) in combination with a large variety of 
sampling techniques. For instance, in microdialysis sampling (for references see Paper 
III and Gilman and Ewing, 19957), sensitivity and selectivity, low sample volume, and 
fast analysis time of the CE method, has increased the temporal resolution of this 
sampling technique dramatically. Also, in combination with the push-pull cannula 
g 
sampling technique, CE analysis of, for example, neuropeptides have been performed . 
Furthermore, the direct analysis of human cerebrospinal fluid (CSF) has been 
accomplished as well as the analysis of neurotransmitters in tissue, single cells, and 
cell cultures. The detection of neuropeptides has been a most challenging goal since 
they exist in very low concentrations and are difficult to detect with most analytical 
methods9"12. 
With the developement of new CE separation and detection methods, their 
application to neuroscience and neuroimmune interactions has moved forward. The 
following is a more thorough description of the applications, where CE has been 
employed in this thesis. 
CSF, secreted mainly by the choroid plexus, is the body fluid which is most likely 
to reflect disturbances in the central nervous system (CNS). The CSF is a serum 
filtrate, i.e. -70% of the proteins it contains are plasma derived and -30% of the 
proteins are related to the brain tissue. The CSF exists at equilibrium with the 
extracellular fluid surrounding the CNS cells, and is known to provide a constant 
chemical environment for the cells within the brain. Among the molecules found in 
CSF are a wide spectrum of neurotransmitters or neurotransmission derived molecules, 
e.g. amino acids, amino sugars, short peptide fragments, neuropeptides and larger 
proteins. Measurement of such molecules might potentially be useful as markers, to 
elucidate the CNS involvement in various diseases. Furthermore, these markers may 
assess the degree of damage in the CNS and enable an estimation of the prognosis. 
Finally, they might be used to evaluate the effects of pharmacological interventions. 
9 
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As an example changes in amino acid levels in CSF (as described in Paper I) have 
been noticed in many CNS diseases, i.e. chronic schizophrenia13, multiple sclerosis14, 
IS 16 17 22 Parkinson's disease , Alzheimer's disease (AD) , and other CNS related disorders " . 
These changes have been analysed employing a large variety of techniques, including 
reversed-phase chromatography, ion-exchange chromatography and isotachophoresis. 
There are, however, only a few reports on the analysis of human CSF by CE, using 
either of the UV-detection23' 24 or laser-induced fluorescence detection (LIF)25 
technique. 
Our study (Paper I) was the first to present any quantitative data from patients with 
different disorders. Just recently a study of free amino acids and primary amines in 
CSF from leukaemic children was reported26, further indicating the usefulness of CE in 
clinical studies. 
During an ongoing neurodegenerative process, a higher turnover rate within nerve 
cells and of synapses may be reflected as an increase, or decrease, in related molecules. 
The turnover rate of synapses might be monitored by measurements of synaptic vesicle 
proteins in CSF. The process of synaptic transmission involves many different 
proteins, e.g. rab3a, synaptophysin and synaptotagmin, all of which have important 
functions in vesicle trafficking, docking to, and fusion with the synaptic plasma 
membrane. 
In Paper II the development of a method for analysing one of these synaptic 
proteins (i.e. synaptotagmin) in CSF was presented. In this process, CE was employed 
as a tool to study the purity and the characteristics of the protein. CSF markers might 
help to guide clinicians in their decisions regarding treatment, and help to indicate the 
disease prognosis. Furthermore the CSF markers might give valuable clues to solve 
the pathophysiological mechanism behind CNS diseases. 
One of the most exacting methods used to monitor CNS changes is the 
27 
microdialysis technique , which permits continuous monitoring of extracellular levels 
of biomolecules in vivo. 
10 
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Microdialysis is a technique where a small probe tip with a semi-permeable 
membrane is placed inside the tissue of interest. On the inside of the probe a solution 
is pumped past the inner surface of the membrane. Analytes are osmotically 
transported across this membrane from high concentration to low. This technique 
offers the advantage that no volume of fluid is being removed from the tissue. The 
probe may also be used to deliver drugs or bioactive substances to a local area of the 
brain, with subsequent sampling by the same probe. Most studies using microdialysis 
sampling have been performed in rat cerebrum, however clinical applications in 
humans have been reported28. As this sampling technique involves a continuous flow 
of perfusate fluid across a membrane, a rather high dilution factor for sampled 
molecules occurs. Thus sensitive and selective analytical methods are required to be 
able to monitor small changes in trace levels. 
In Papers III-IV the use of a sensitive CE method is described, employing laser-
induced fluorescence detection and pre-column derivatization of the samples. In Paper 
III potassium induced release of neuroactive amino acids in the periaqueductal grey 
(PAG) matter is studied. This data is directly compared with two different HPLC 
methods which are commonly used for these kinds of analyses. In Paper IV the effect 
of morphine on the basal release of y-amino-n-butyric acid (GABA) is monitored, and 
the activation of the |i-receptor on the GABA interneuron in the PAG has been studied. 
The high sensitivity of the CE-LIF method is one tremendous advantage which made it 
possible to follow these small changes at the nanomolar level. 
As stated above, CE has become an effective analytical tool with many 
applications to bona fide neurobiological questions. Its application in immunology, 
however, has not been widespread. There is a wide variety of molecules to study in 
neuroimmunological interactions, with a multitude of characteristics. The most 
examined class of molecules are the cytokines, or neurokines, due to their regulatory 
functions in nervous tissue as well as in the immune system. It is becoming 
increasingly clear that the connections between the immune and nervous systems are 
29 • involved in many functions of the mammalian life cycle . Classical neurotransmitters 
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regulate the central and peripheral nervous systems, but these regulators may in fact be 
acting as immunotransmitters or neuroimmune transmitters. CE should be a very 
powerful technique for the separation and detection of neuroimmune transmitters. 
The main analytical tool for immune molecule detection is enzyme linked 
immunosorbent assay (ELISA)30. This method provides good sensitivity with 
detection limits down to picogram levels. An alternative to this method is the 
ELISPOT assay31, where products from a single cell can be detected. In addition some 
cell clones specifically responding to a specific interleukin by proliferation can be used 
to detect a given cytokine. The proliferative response can then be analysed by 3H-
thymidine incorporation. In many immunological methods the results are given as 
titers, not as absolute concentrations. As our knowledge of immunological interactions 
deepens, the need for quantitative methods increase. 
In the few published applications of CE in immunology to date, immunological 
properties, e.g. antibody-antigen interactions, have been used as tools in CE, but CE 
has not been used as a tool in immunology. The possibility of resolving a large variety 
of molecules, i.e. small ions to large macromolecules, has been another advantage of 
this method. Earlier applications of CE were more concerned with pure protein 
chemistry than with immunology, especially concerning the analyses of recombinant 
proteins and hydrolysis of these proteins32'36. The purities of antigen binding F(ab')2 
regions, antibodies, as well as the thermal stability of antibodies have all been assessed 
using CE37"41. The technique has also been applied to the analysis of the nucleotide 
pools in lymphoma cells, in ucon-coated columns with on-column UV-detection42. 
Yet another important application of CE has been in immunoaffinity assays where the 
mobility shift due to the binding of an antibody to an antigen is used for detection and 
quantification. CE with laser-induced fluorescence detection, having low detection 
limits and good separation capacity, is a more than suitable system for this type of 
assay. However, this technique requires an antibody with a high specificity and that 
the labelling of the antigen results in a complex of antigen-antibody that is well 
separated from the non-labelled complex (Figure 1). 
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\/f \A Labeled antigen 
CE with LIF detection 
* 
Time 
Limited amount of antibody 
Figure 1. A schematic drawing of the competitive immunoassay procedure. 
In this competitive immunoassay, the amount of free labelled antigen is directly 
proportional to the amount of antigen present in the sample, as seen in expression (1), 
where Ag=antigen, Ag*=labeled antigen, and Ab=antibody: ' 
; + Ag* +Ab <=> Ag-Ab + Ag*-Ab 
mat 
This technique has been used to assay several different antigens (for background 
see43"46). By using affinity CE enzyme interactions4', protein-protein interactions' 
antibody-antigen interactions53"60, protein-carbohydrate interactions61"63, and protein-
drug interactions64"68 have been determined. A modification of the affinity methods is 
the use of protein G immunoaffinity for preconcentration in CE69. To use CE as a tool 
in immunology, we reported the analysis of single lymphocytes from human CSF by 
CE with amperometric detection (Paper V). This analysis led to the discovery of 
endogenous catecholamines in cells derived from the immune system. Thus extracts of 
ex-vivo and cloned lymphocytes were also examined for their catecholamine content. 
The possible effects of catecholamines on lymphocytes were studied by analysing their 
48-52 
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proliferative response and differentiation (Papers V-VI). Both the proliferation and the 
differentiation of the immunocompetent cells were significantly suppressed by 
exposure to catecholamine. In order to clarify the mechanism behind these effects, the 
cells were examined for signs of apoptosis, both with flow cytometry, measuring 
genomic DNA fragmentation, and by measuring of apoptotic marker proteins (i.e. Bcl-
2/Bax and Fas/FasL) using western blot techniques. 
Apoptosis is the process whereby developmental or environmental stimuli activate 
a genetic program to accomplish a specific series of events that culminate in the death, 
and efficient disposal of a cell. Necrosis is usually considered to result from physical 
injury, and is not genetically controlled, whereas apoptosis is a deliberate and 
genetically controlled cellular response. Also, necrosis is recognised by cytoplasmic 
organelle destruction and loss of plasma membrane integrity, whereas apoptosis is 
associated with cytoplasmic boiling, chromatin condensation, and nuclear DNA 
fragmentation70. However an event that produces necrosis may trigger apoptosis in 
surrounding tissue as a result of the accumulatation of cellular debris. Likewise 
apoptosis may indirectly produce necrosis under some conditions. As seen in Paper 
VI, an apoptotic mechanism involves a rather complicated series of actions, with up-
and down-regulation of different proteins (such as Bcl-2/Bax and Fas/FasL). The Bcl-
2 protein is known to protect against apoptosis71'72, so a decrease of this protein with 
73 
an increase of Bax, an apoptosis induced protein that forms heteromers with Bcl-2, 
strongly suggests an ongoing apoptotic process. The same is valid for the expression 
of Fas. The Fas/FasL interaction is believed to be one of the mechanisms involved in 
suppression of the immune response and in peripheral tolerance74, 75. Antigen 
presenting cells express on their surface an autoreactive antigen as a complex with the 
major histocompatibility complex (MHC). The antigen-MHC complex interacts with 
the T cell receptor on autoreactive T cells. This activates the cells and induces the 
expression of Fas and FasL. These cells then undergo apoptosis through the 
interactions between Fas and FasL. Apoptosis of T cells can take place when Fas and 
FasL are located on different cells, on the same cell, or by release of soluble FasL. 
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Both the flow cytometric method and the analysis of apoptotic marker proteins 
provided evidence of a specific induction of apoptosis in PBMC by catecholamines 
(Paper VI). In a parallel study, the presence and effects of catecholamines in cells of 
murine origin, were examined (Paper VII). This clearly demonstrates that the 
mechanism is general within mammals, and may become an important factor to 
consider in neuroimmunology. 
In this thesis, consisting of seven separate papers, three different detection modes 
for CE have been used. These include two different utilisations of CE in neuroscience 
with special applications for the detection of early markers for progressive 
neurodegenerative disorders. In addition, two different applications of CE in 
neuropharmacology, where neuroactive amino acids have been monitored combining 
CE and microdialysis in rat cerebrum, are presented. Finally, three different 
applications of CE in neuroimmunology are reported. 
The main goal with these studies has been to further develop available CE 
methods, and by further employing this versatile technique, attempt to clarify some of 
the questions that have evolved in neuroscience today. The primary issue has not been 
to push for analytical bench-top markings, but rather to apply the technique to relevant 
biological and clinical inquiries, believing that the quality and applicability of an 
analytical method can not solely be judged from separations of pure standards. 
Hjärnan är ett underbart organ. Den börjar arbeta i samma stund som du vaknar på 
morgonen och slutar inte förrän du kommer till jobbet 
&ro*t 
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2. Principles of capillary electrophoresis 
A large number of review articles6'7'76-99 and books100"106 have been published, 
describing various aspects of CE. Hence, only a short background and description of 
the CE method is given. There are several different modes of CE, i.e. capillary zone 
electrophoresis (CZE), micellar electrokinetic chromatography (MEKC), capillary gel 
electrophoresis (CGE), isotachophoresis (ITP), and isoelectric focusing (IEF). In the 
present thesis only two of these modes have been used, CZE and MEKC. 
Free zone, or CZE, can be used for many different types of molecules. Separations 
are based on variations in mass-to-charge ratios of the analytes. Optimising a CZE 
separation involves selection of a buffer pH which maximises the differences in mass-
to-charge ratios, selecting a polarity appropriate for the sample charge, and applying a 
field strength which provides the best compromise between analysis time and zone 
sharpness. 
MEKC is a separation technique, which in contrast to CZE, permits resolution of 
neutral as well as charged molecules. This is possible due to a combined effect of 
electrophoretic migration and micellar partitioning. Micelles are spherical aggregates 
of surfactant molecules, with an hydrophilic outer surface and hydrophobic interior. 
Sample components have different degrees of interaction with the micelles, which in 
turn serve as a pseudostationary phase within the capillary. Sodium dodecyl sulfate 
(SDS) is the most commonly used surfactant, and forms an anionic micelle which has 
an electrophoretic mobility opposite to the bulk flow in the capillary. The following 
principles are applicable for most CE modes; however, some exception do exist. 
Historical perspective of electrophoresis and its development 
In Sweden there has been a long tradition of electrophoresis from the early part of 
this century. Electrophoresis has been defined as the differential movement of ions by 
attraction or repulsion in an electric field. Arne Tiselius' development of the moving 
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boundary electrophoresis technique107, based on the first electrophoretic experiments 
performed by the Russian physicist Reuss in 1809108, and the application of the method 
for examination of molecules in biological fluids was a major breakthrough for 
biochemistry. Placing protein mixtures between buffer solutions in a tube and 
applying an electric field, he found that sample components migrated in a direction and 
at a rate determined by their charge and mobility. This innovation rendered Tiselius 
the Noble Prize in 1948. In combination with the ultracentrifugation technique109 
developed by Tiselius' mentor The Svedberg (Noble Prize in 1926), this technique 
allowed for complex biological solutions to be both qualitatively and quantitatively 
analysed. However, the moving boundary technique had its limitations and the major 
drawback was the large inner diameter (i.d) of the glass tubes used. 
Already as a preliminary note in 1958110 and later in his thesis in 1967111, the 
student of Tiselius, Stellan Hjertén, described a free zone electrophoresis method in 
rotating quartz capillaries (along their longitudinal axis), offering several methods for 
fast, efficient separation of ionic species and separation of macromolecules important 
in the area of analytical biotechnology. The lack of sensitive UV-detectors postponed 
the use of narrow-bore capillaries for some time; however, this together with the 
invention of fused silica capillaries in 1978 was the groundstone for the capillary 
electrophoretical methods we know today. During this period in Tiselius' and later 
Hjertén's laboratory, many other important bioanalytical techniques were designed: 
including adsorption chromatography, size exclusion gel chromatography, 
hydrophobic-interaction chromatography and Polyacrylamide gel electrophoresis, 
which are still used today. 
In 1968, Everaerts described an apparatus for displacement electrophoresis in his 
thesis"2, still in rather large i.d. (0.6 mm) tubes with the disadvantage of convection, 
and thermal zone deformation. In 1974 Virtanen reported on Potentiometrie detection 
of electrophoretically separated solutes in 200 to 500 |im i.d. Pyrex tubes"3. This 
work dealt with zone electrophoresis, and pointed out many of the unique advantages 
of using small diameter tubes. In 1979 Mikkers et al. refined this technique to 200 
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i.d. teflon tubes, and obtained separations with plate heights of less than 10 (im114. 
Jorgenson and Lukacs115 advanced the area using even narrower capillaries (75 (im) 
which resulted in plate heights of just a few micrometers. Hjertén is still very active in 
research and has, over the last thirty years contributed with many new theoretical and 
practical approaches to CE, including coating the capillary walls with polymers in 
order to reduce the absorption of large molecules116, "7, isoelectric focusing 
118 119 techniques , and improved sample handling 
Although CE was not offered as a commercially available instrument until the end 
of the 1980's, there is already an impressive number of applications of CE in a large 
number of areas, including biotechnology, pharmacology, neurobiology, etc. The 
number of CE papers is increasing exponentially, with approximately 50 new 
applications published per month. This has produced a total number in excess of 3000 
published papers by the spring of 1996. 
The theory of capillary electrophoresis 
As CE technology has evolved, it has become apparent that an immense versatility 
in separation selectivity can be achieved by simple changes in the composition of the 
electrophoresis buffer. A CE instrument is a simple apparatus, both commercially 
available but also well suited for "home building" (Papers V-VII, Figure 2). In brief, 
the ends of a buffer filled fused silica capillary are placed in buffer reservoirs. Sample 
is loaded onto the capillary by replacing one of the reservoirs (i.e. normally the anodic 
one) with a reservoir containing the sample and applying an external pressure (Papers 
I-IV), an electric field (Papers V-VII), a vacuum at the outlet end, or by just causing a 
siphoning effect by elevating the sample reservoir. A high-voltage power supply is 
connected across the capillary creating an electric field that will cause the separation. 
Towards the cathodic end of the capillary, a detector is placed. 
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Figure 2. Schematical drawing of a principle CE instrumentation with a buffer-
filled fused silica capillary positioned in-between two buffer reservoirs, across which a 
high potential is connected in order to create an electric field inside the capillary and 
cause a separation. Towards the cathodic end of the capillary a detector is arranged 
and often a computer is employed for the data aquisition. 
Electrophores is 
Electrophoretic separation is based on differences in ion velocity in an applied 
electric field. This velocity can be calculated by equation (2), where ve=ion velocity 
(cm/s), |ic=electrophoretic mobility (cm Ns), and E=applied electric field (V/cm): 
v = h F (Ti ve H-e11 \£) 
H ' Ï ' W ' i f i  '  , " ; 5  " ? •  e  £ % t y * ^ •  V ' 1  
The electrophoretic mobility (p.e) can be calculated by use of the Stokes equation, 
where the electrical force acting upon an ion is balanced by the frictional drag it 
experiences passing through a medium. During electrophoresis a steady state is 
attained, where the forces are equal but opposite. The electric force can be calculated 
by equation (3), where FE=electric force (N), and q=ion charge (C): 
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The frictional force for a spherical ion in a hydrodynamic continuum can be 
calculated by equation (4), where FF=frictional force (N), resolution viscosity 
(Ns/cm2), and r=ion radius (cm): 
F F = -  6  7i Q r ve (4)  
At a steady state, the combination of equation (2), (3) and (4), gives the equation 
(5): 
M e = q / 6  7TT)R (5) 
- SiâïK SÉ» A- . 
From this equation it is evident that small, highly charged species have high 
mobilities whereas large, minimally charged species have lower ones. However this 
equation does not take into account the electric forces between analyte and solvent 
molecules, and does not apply to ions similar in size to the solvent molecules. 
Furthermore, the ionic shape, the attached solvent shell, the ^-potential (the zeta-
potential, i.e. the potential at the slip plane between the ion and the solution; the higher 
the surface charge, the higher the Ç-potential), the ionic strength, the pH (i.e. solute 
pKa), and the temperature are all significant factors. Therefore, the physical constant 
of pe found in standard tables, determined at the point of full solute charge and 
extrapolated to infinite dilution often differs from the empirically found |ae. The 
apparent electrophoretic mobility (|ia in cm2/Vs) can be calculated by equation (6), 
where Ldet=length of the capillary to the detector (cm), Lt0t=total length of the capillary 
(cm), V=applied voltage (V), and ^migration time (s): 
In order to calculate the actual mobility for a given substance in an electrophoretic 
separation the electroosmotic flow must be accounted for. 
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Electroosmosis 
The phenomenon of electroosmotic flow (EOF) is a consequence of the silica 
surface charge inside the capillary. The ionizable acidic silanol groups on the capillary 
wall will dissociate and the surface will be negatively charged at pH values above 2. 
Positive ions in the buffer will act as counter ions and will be attracted to the negative 
surface. Some ions are adsorbed onto the surface, but no complete charge 
neutralisation will occur. The excess of hydrated positive ions in the vicinity will form 
a diffuse electrical double layer (Figure 3). The potential difference close to the wall is 
the ^-potential. The Ç-potential (V) can be calculated by the equation (7), where 
j!eo=electroosmotic mobility (cm /Vs), and e=dielectric constant (As/Vm): 
C = 4 7C TI LIE0 / e (7) i r~eo v / 
® a - ® 
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@ © A 
.Ü _§L 
© © © © 
0 ^ 0 0  g  ^  0  ^  
Diffuse layer 
W W T & W W T & W & T &  v Stern layer 
\ Capillary wall 
Figure 3. Schematic drawing of the double layer at the capillary wall. 
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The EOF is the bulk flow of liquid in the capillary, and results from the effect that 
the applied electric field has on the cations in this diffuse mobile part of the double 
layer, carrying water with them. Since the pH determines the charge of the surface, 
and the charge of the surface determines the Ç-potential, the EOF increases with 
increasing pH. The ^-potential is related to the charge per unit surface area, the 
number of valence electrons, and the square root concentration of the electrolyte. 
Since this is an inverse relationship, increasing the concentration of the electrolyte, 
resulting in a compression of the double layer, will decrease the EOF. 
There are many features to consider with the EOF in the capillary, among those, 
the flat flow profile (Figure 4). Since the driving force of the flow is uniform already 
close to the wall (at a distance approximately two times the thickness of the double 
layer), the pressure drop over the capillary is almost zero. Therefore, little or no 
dispersion of solute zones are found, in contrast to systems with parabolic flow. 
Also, the EOF permits simultaneous analysis of cations, anions and neutral species 
in a single run. At high and neutral pHs, when the silanol groups are mostly 
deprotonated, the EOF is stronger than the electrophoretic mobility, sweeping all 
species towards the negative cathode (Figure 4). At low pH, when most silanol groups 
become protonated, the EOF is still directed against the cathode even if it is small; 
however, most zwitterions and cations will also migrate in the same direction and pass 
the detector. The EOF is sometimes hard to control, resulting in poor reproducibility 
of the separations. In order to control and change the EOF several factors can be 
varied. As already mentioned, the electric field strength, the pH, the ionic strength of 
the solvent, and the temperature (changes viscosity 2-3% per °C), are all very 
important for the EOF. Also, organic modifiers like dimethyl sulfoxide (DMSO, 
Papers I, III-IV) when added to the buffer, will change both the ^-potential and the 
viscosity, and normally lead to a decreased EOF. Finally the EOF can be controlled by 
adding dynamic coatings (e.g. surfactants and hydrophilic polymers) to the buffer, or 
by covalently coating the capillary wall. 
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There are a number of other factors effecting the efficiency of a capillary 
electrophoretic separation, (i.e. sample adsorption, electrodispersion, laminar flow due 
to unlevelled buffer reservoirs or Joule heating, the injection plug length, and 
longitudinal diffusion), which in most cases can be controlled and calculated for under 
ideal conditions. However empirical experiments are often both simpler and faster. 
Direction of flow ^ 
Figure 4. Differential analyte migration zones in a capillary, where small cations 
migrate fastest, small anions migrate slowest, and non separated neutrals are all 
carried at the velocity of the flat flow profile electroosmotic flow. 
Analytical parameters in capillary electrophoresis 
By using an electroosmotic flow marker (a neutral species), the EOF velocity can 
be empirically determined and a true or effective electrophoretic mobility for a given 
substance can be calculated by the equation (8), where ineffective electrophoretic 
mobility (cm /Vs), teo=migration time for the electroosmotic marker (s), and where fie 
will be positive for a cation and negative for a anion: 
He= (1 / t,n - 1 / teo) Lde[ Lto, / V (8) 
<• , ' -y, ^ v ' . Î. i " H'w tf ' f' - v, r _ .-5-.; v . - .  '  .  -  ,  ,  -
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The relative retention time (Vt^,) for an analyte can also be calculated from 
120 
equation (9) , where k= constant, M=molecular weight (g/mole) and Z=net-charge 
(C): 
tm/teo=kM2/3/Z (9) 
The net-charge for an analyte, can be calculated from equation (10)121 by summing 
the charged groups on the molecule, where u+= alkaline group and u.=acidic group: 
-  • •  . • •  :  
- -V ' 
/ ( 1  +  1 0 1  VC ' is mi 
Also, the efficiency of separation for a given peak, expressed in number of 
theoretical plates (sometimes over 106 of them are achieved by CE), can be calculated 
directly from the electropherogram by equation (11), where N=number of theoretical 
plates, and wb=baseline peak width (s) for a Gaussian peak: 
N=16(tra/wb)2 (11) 
Depending on the peak shape and signal to noise ratio, it is sometimes better to use 
the peak width at half the peak height (wl/2), as shown in equation (12): 
N= 5.54 fe/wja)2 (12) 
or at the peak width at 10% of the peak height (w10%), as shown in equation (13): 
N= 18.5 (Ww,^2 (13) 
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However, none of the above provided equations take into account the skewed peak 
in the determination of N. 
Finally, the resolution between two adjacent peaks (RJ, can be calculated by 
equation (14), where t^, t^ , wbl and wb2, are the migration time (s) and baseline peak 
width (s) for each peak respectively: 
Rr 2 (W-tmi) / (wbl+wb2) (14) 
Depending on the injection technique applied, the amount of injected material can 
be calculated or measured. When using pressure injection as in Papers I-IV, the 
minimum injection volume is approximately 1 nL. This is a rather large volume 
compared to the volumes injected by electrokinetic injection (Papers V-VII), where 
injection volumes down to 270 fL have been reported122. However, it should be noted 
that the pressure injection technique, in contrast to electrokinetic injection, delivers a 
more representative sample without bias according to the charge of the injected 
species. The volume injected with pressure injection can be calculated using equation 
(15), where Vol;=injected volume (L), AP=pressure difference across the capillary 
(mbar), dj d =inside diameter of the capillary (m), and tj=injection time (s): 
Voir AP du4 H t; /128 ri L tot (15) 
The electrokinetic injection techniques involve both electrophoresis and 
electroosmosis, and the injected amount can be calculated by equation (16), where 
Qi=quantity injected (mole), A=cross sectional area of the capillary (m2), and 
C=concentration of the analyte (mole/L): 
Qi= 0v+ Heo) V A C tj / Ltot (16) 
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Under normal electrophoresis conditions, cations will move faster than the EOF 
and anions slower. Thus, the apparent injection volume for cations and anions differs 
from the volume removed from the system. Thus, the apparent injection volume for 
each component may be calculated by equation (17), where Vola=apparent injection 
volume (L): 
Vola= (He + Keo) V A t; / Ljot (17) 
Detection in capillary electrophoresis 
In this thesis three different detection modes have been utilised (i.e. laser-induced 
fluorescence in Papers I and III-IV, absorption detection in Paper II, and 
electrochemical or amperometric detection in Papers V-VII). These will be shortly 
described below. 
Laser-induced fluorescence detection 
Optical detection techniques for CE have recently been reviewed by Pentoney and 
123 Sweedler The laser-induced fluorescence technique (LIF) has proven to be the 
most sensitive detection scheme for CE with reports of single molecule detection124"127. 
Despite the exceptional detection limits available, this technique is only beginning to 
be applied to neurochemically interesting materials. The laser provides a fine source 
of excitation due to its high intensity of monochromatic light and low beam 
divergence. In contrast with UV-detection, LIF directly obtains the signal against a 
dark background and is thus many orders of magnitude as sensitive. However, unless 
the natural fluorescence of a compound can be exploited128, it is necessary to derivatize 
the analyte with a fluorescent label or "tag". 
The explanation of fluorescence is easily found in physical chemistry textbooks129. 
Briefly, in an often used set-up, a fibre-optic cable transmits laser light from the laser 
to the detector and illuminates a section of the capillary. Thus, the initial absorbance 
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takes the molecule to an excited electron state by the transfer of an electron from its 
singlet ground electron state (S0) to the higher singlet excited electron state (S,). The 
fluorescence is the emission of photons due to the SrS0 transition, when the molecule 
returns to its singlet ground electron state again. The emitted light (at a longer 
wavelenght compared with excitation light) is then collected by an ellipsoidal mirror 
and focused back onto a photomultiplier tube. In the excited state the molecule is 
subjected to collisions with the surrounding molecules (e.g. of the solvent), and as it 
gives up energy it steps down the ladder of vibrational levels. If the surrounding 
molecules can not accept the larger energy difference needed to lower the molecule to 
the ground electron state, it may undergo spontaneous emission, emitting the 
remaining excess energy as radiation. 
The majority of CE-LIF applications involve pre-capillary labelling with reagents 
similar to those used with fluorescence detection in HPLC, although on-column 
derivatization for CE has been developed130' 131. Normally, the choice of agent is 
dependent on the nature of analyte and the laser available. Schwartz et al. recently 
132 gave an overview of available lasers for CE-LIF detection . The derivatizing agent 
used in Papers I and III-IV, 3-(4-carboxybenzoyl)-2-quinoline-carboxaldehyde 
(CBQCA)133, forms highly fluorescent isoindole products, analogous to the products of 
o-phtaldialdehyde (OPA) and naphthalene-2,3-dicarboxaldehyde (NDA)134, when 
reacting with a suitable nucleophile or compounds containing primary amines. 
There are several important advantages realised by the use of CBQCA, including 
detection limits in the nanomolar range, excellent linearity, compatibility with MEKC, 
fast reaction time, and good product stability. Background fluorescence is minimal 
because CBQCA itself does not fluoresce. Hence, no purification of CBQCA 
derivatives is required prior to analysis. Unfortunately, most peptides and proteins 
present multiple sites, which can be tagged resulting in many labelled species. 
Interesting new developments include the employment of fluorescently labelled 
immunochemicals, described earlier in the introduction, and post-column 
derivatization135'136. 
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Absorption Detection 
Detection by UV or visible absorption is the most common, commercially 
available technique used with CE, primarily due to its nearly universal detection 
nature. Typically, a small portion of the polyimide coating on the capillary is removed 
by heat or acid leaching to form an on-column detection window (see Figure 2). 
Detection is most often carried out by absorbance measurements from below 200 nm 
up through the visible spectrum, and many array and scanning detection systems are 
available. Since the optical window is directly in the capillary there is no zone 
broadening as a result of dead-volume or component mixing. However, due to the 
short path length resulting from the narrow bore of the capillary, it is a relatively 
insensitive technique, when compared to most other techniques, and is therefore 
usually not useful for the low-levels of neurochemicals typically extracted in 
neuroscience experiments. In fact, due to the curvature of the capillary, the actual 
pathlength in the capillary is less than the i.d., since only a fraction of the light passes 
directly through the centre. Since UV-detection is universal (i.e., suitable for many 
types of analytes), it is suitable to use for purity analysis and characterisation as in 
Paper II. 
Electrochemical or Amperometric Detection 
CE with electrochemical detection has been widely used to answer neurologically 
interesting questions, and was recently reviewed by Ewing et al.98 This detection 
scheme has allowed the use of extremely small capillaries (down to 2 pm i.d.). In 
short, electrochemical detection involves electron transfer from an analyte, at a surface 
of an electrode. If the potential at the electrode surface is greater (more positive for 
oxidations, more negative for reductions) than that required for the electrolysis of the 
analyte, an oxidation of the analyte takes place and released electron(s) reach the 
electrode surface. This current is subsequently converted to a voltage which, through 
an interface is recorded, e.g. by a computer, and converted to an electropherogram. 
The resulting current is directly proportional to the concentration of solute reaching the 
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electrode surface, as can be seen from equation (18), where Q=number of charges (C), 
n=number of moles of electrons lost or gained in the transfer process per mole of 
material, N=moles of material (mol), and F=Faraday's constant (96485 C/mol of 
electrons): 
Differentiation of equation (18) with respect to time yields the current, which is the 
measure of the rate at which material is converted. Equation (19) therefore relates a 
measurable quantity, the current (i), to the fundamental redox process occurring in the 
cell: 
Fortunately, many neurochemicals of interest are easily oxidised in their natural 
state. This gives electrochemical detection two distinct advantages; first, no 
derivatization is needed and, second, as a consequence of the first, ultrasensitive 
detection (comparable to that offered by laser-induced fluorescence detection) is 
available for direct in vivo measurements. Amperometric detection has been 
accomplished both off-column (Paper V) and on-column (Papers VI-VII) in this thesis. 
The experimental set-up for off-column detection was earlier described in great detail 
by Wallingford and Ewing137"142. This apparatus employs a piece of porous glass 
tubing over a small crack in the capillary to allow electrical isolation of the separation 
potential field from the potential applied to the amperometric electrode. 
The experimental set-up for on-column or end-column detection has been 
described in detail by Sloss and Ewing143. Briefly, the apparatus consisted of a 
capillary placed between two buffer reservoirs with high voltage applied at the 
injection end, and the detection reservoir containing the electrochemical detector was 
held at ground potential (see Figure 5 in Methods). Detection of the easily oxidised 
Q = n N F  (18) 
dQ/dt = i = nF dN/dt (19) 
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analytes was performed in the amperometric mode with a two-electrode configuration. 
A carbon-fibre microelectrode was inserted into an etched funnel structure in the end 
of the capillary and held at the amperometric detection potential versus a reference 
electrode. Due to the large resistance in small i.d. capillaries (~1012 Q), no decoupler 
is needed to shield the small electric current produced in the column upon application 
of the separation potential. 
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3. Aims of the study 
Det är med idéer som med småbarn. Man tycker bäst om sina egna 
Jt£oa> JfïartwAon/ 
to explore CE with laser-induced fluorescence detection, as a new analytical tool 
in medical neuroscience for quantitative analysis of neuroactive amino acids in 
CSF (Paper I), and to monitor local transient changes of amino acid levels in 
microdialysis samples from rat cerebrum (Papers III-IV). 
to apply CE with UV detection as part of the analysis of synaptic vesicle proteins 
in CSF (Paper II). 
f/7 to develop CE with electrochemical detection as a tool in neuroimmunology, for 
the analysis of catecholamine neurotransmitters down to the single cell level 
(Papers V-VH). 
f!? to apply these techniques to previously unanswered neuroimmunological 
questions, and to study the production of catecholamines in immunocompetent 
cells (Papers V-VII). 
tO? to investigate how catecholamines can influence the reactivity of 
immunocompetent cells by regulation of proliferation, differentiation and 
induction of apoptosis (Papers V-VII). 
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Jag använder inte bara den hjärna jag har, utan också alla dem som jag kan låna 
Woot/rotv- eft^Aon/ 
Patients (Papers I-II) 
The studies performed with patient material was approved by the Ethics 
Committee, Göteborg University. 
The pooled control 
The control pool (pool CCSF, Paper I) consisted of 80 human CSF samples. The 
samples were sent to the laboratory for protein analysis, but had normal values of 
albumin and albumin ratio, and no signs of intrathecal production of immunoglobulin 
G or M. The samples were from individuals older than 15 years of age. 
The Alzheimer's type I patient pool 
The Alzheimer's pool (Pool ADCSF, Paper I) consisted of five samples (from 2 
men and 3 women; 60 to 68 years of age; mean ± standard error of the mean (SEM) 
age, 62.8 ± 1.6, duration of dementia; mean ± SEM duration in years, 5.8 ± 1.5). All 
patients underwent thorough clinical investigation. The diagnosis of Alzheimer's 
disease was made in accordance with the NINCDS-ADRDA criteria144. All the AD 
patients belonged to the subgroup AD type I145. 
The AD-matched healthy control pool 
The Alzheimer's age matched control pool (Pool AMCCSF, Paper I) consisted of 
five samples (from 4 men and 1 woman; 66 to 70 years of age; mean ± SEM age, 67.4 
± 0.7). These individuals had no symptoms or signs of psychiatric or neurologic 
disease, normal values of albumin and albumin ratio, and no signs of intrathecal 
production of immunoglobulin G or M 
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CSF sample from a 4 year old girl with undiagnosed muscular pain 
Patient A (Paper I), admitted to the Department of Paediatrics for neuro-muscular 
investigation, was included in this study. She was screened and showed no oligoclonal 
bands in CSF, and no changes in monoamine metabolites. No pathological values 
considering albumin, IgG or IgM, ß-endorphin, and neuropeptide Y, were found in her 
CSF. 
CSF sample from a 3 year old girl with a diagnosis ofprogressive epilepsy 
Patient B (Paper I), was admitted to the Neurochemical laboratory for protein and 
monoamine metabolite analysis, but no pathological values was found in her CSF. 
CSF sample from a 7 year old girl with suspected autism and mental 
retardation 
Patient C (Paper I), was included in this study. She was admitted to the 
Department of Paediatrics for investigation and diagnosis. Routine analysis of proteins 
and monoamine metabolites in CSF showed no pathological values. 
CSF sample from a 9 year old boy subjected to allergic investigation 
Patient D (Paper I), was included in this study. He suffered from undiagnosed 
headache and a swollen forehead. The CSF was admitted to the Neurochemical 
laboratory for routine analysis of proteins and monoamine metabolites in CSF. No 
pathological values were found for IgG, IgM, albumin, ß-endorphin, neuropeptide Y 
and somatostatin. However, he had high values for eosinophile cells and IgE in his 
blood and was diagnosed to have a parasitic infection. 
CSF samples used for synaptotagmin analysis (Paper II) 
In Paper II, pooled CSF from 4 patients with early onset (before 65 years of age) 
AD, 2 men and 2 women, aged 61-67 years, was analysed for synaptotagmin. The 
diagnosis was made in accordance with the NINCDS-ADRDA criteria144. Also, 
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pooled CSF from 4 healthy individuals, 2 men and 2 women, aged 59-66 years, was 
analysed for comparison. This group was described previously in detail146. 
Brain tissue samples usedfor synaptotagmin analysis (Paper II) 
Synaptotagmin was analysed in brain tissue specimens from AD patients, aged 
matched controls, and patients with schizophrenia (Paper II). All AD patients had a 
histopathological score147 of five or above. AD was subdivided based on the age at 
onset into early-onset AD (EAD, age at onset before 65 years of age), in total 8 
patients, mean age 71 ± 5.9 years, and late-onset AD (LAD, with age at onset after 65 
years of age), in total 11 patients, mean age 83 ± 7.6 years. The severity of dementia 
was estimated using the intellectual subscale in a geriatric rating scale148. 
The control group consisted 9 patients, mean age 71 ± 14 years, who had died from 
cardiac or malignant disease. Their medical records revealed no history of dementia, 
psychiatric or neurological diseases. All control patients had a histopathological 
score147 of four or lower. 
The diagnosis of schizophrenia was made in accordance with the DSM-III-R 
149 
criteria . This group consisted of 7 patients, mean age 80 ± 11 years, who had 
schizophrenia for several years, but no symptoms or signs of dementia, 
cerebrovascular disease, or other neurological disorders. A histopathological 
examination was not performed in this group. 
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Animals (Papers III-IV, VII) 
The studies performed with animal material were approved by the Local Animal 
Ethics Committee of northern Stockholm and the Ethics Committee, Göteborg 
University. 
Rats 
In Papers III and IV, male Sprague Dawley rats (ALAB, Södertälje or B&K 
Universal, Sollentuna) were housed at 12 h light and dark cycle, with food and water 
ad libitum. After the surgery the animals were allowed to recover for two days in 
single cages before the experiment started. 
Mice 
In Paper VII, female DBA/1 mice, 12-19 weeks old were bred in the animal 
facility of the Department of Clinical Immunology in Göteborg, but originally 
purchased from Harlan Olac farm (Bicester, UK). The mice were housed 10 in each 
cage and were fed standard laboratory chow and water ad libitum under standard 
conditions of temperature and light. 
Cerebrospinal fluid sampling (Papers I-II) 
In Papers I and II, the first 12 mL of the CSF (3 mL for children under 16 years of 
age), was collected in plastic tubes and gently mixed to avoid gradient effects. Lumbar 
punctures were performed in the L3-4 or L4-5 interspace, in the morning with the 
patient in a recumbent position. 
All CSF samples with more than 500 erythrocytes per |iL were excluded. A blood 
sample was taken at the same time. CSF and serum samples were stored in 1 mL 
portions at -20°C or -80°C prior to analysis. Quantitative determination of albumin in 
CSF and serum was performed by rocket immunoelectrophoresis150. The albumin ratio 
(CSF albumin in mg/L divided by serum albumin in g/L) was used as the measure of 
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the blood-brain barrier function151, to be able to exclude samples from patients with 
blood-brain barrier dysfunction, with an increased influence of molecules from serum 
in their CSF. 
Human brain tissue sampling (Paper II) 
At autopsy the brains were weighed, and infarcts, lacunas, or other macroscopical 
pathological changes other than brain atrophy were not noted on circumspect gross 
examination. The left hippocampal formation and frontal cortex (Brodmann area 9) 
was dissected out, homogenised in liquid nitrogen, and stored at -80°C prior to 
biochemical analyses. 
Microdialysis samples from rat cerebrum (Papers III-IV) 
Microdialysis was used together with CE-LIF in Papers III-IV. A stereotaxic 
instrument (David Kopf, Tujunga, CA, USA) was used for implantation of a guide 
cannula (CMA/12 Guide/CMA Microdialysis, Stockholm, Sweden) under halothane 
anaesthesia. A hole was drilled in the skull (2.5 mm (Paper III) or 1.5 mm (Paper IV) 
lateral to the midline and 7.3 mm caudal to bregma) and the guide cannula with a stylet 
in place was inserted with a trajectory, angled 22° (Paper III) or 14° (Paper IV) from 
the midsagittal plane to a depth of 4.6 mm (Paper III) or 4.0 mm (Paper IV) ventrally 
from the dura. The tip of the guide cannula was placed in immediate vicinity of the 
ventrolateral PAG. By this approach, the microdialysis probe (CMA/12, membrane 
diameter 0.5 mm, membrane length 2 mm, molecular cut off 20000 D) could be placed 
with the dialysis membrane in the ventrolateral PAG without interfering with the 
aqueduct. Dental cement and two anchoring screws in the scull fixed the guide 
cannula. The stylet was left in the guide cannula until the insertion of the 
microdialysis probe one hour before the start of the dialysis experiment. 
The perfusion fluid contained 148 mM NaCl, 2.7 mM KCl, 1.2 mM CaCl2 and 
0.85 mM MgCl2. Potassium induced release was obtained by switching to a perfusion 
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medium containing 100 mM KCl for 15 min. For the study of calcium independent 
basal and potassium induced release, calcium was removed and 12 mM MgCl2 was 
added to the perfusion medium. When studying the effect of morphine and naloxone , 
the rats were perfused with a modified Ringer's solution containing 100 pM morphine 
alone or in combination with 100 pM naloxone. All dialysis fluids maintained the 
same osmolarity. 
The experiments were conducted after two days of postoperative recovery. After 
the insertion of the microdialysis probe and a washout period of one hour, allowing for 
the stabilisation of the system, sampling was started. Dialysis samples were collected 
every 15 min at a perfusion rate of 7 ^L/min and immediately stored at -20°C. The 
rats were kept in a device for microdialysis in freely moving rats (CMA/120, CMA 
Microdialysis, Stockholm, Sweden) throughout the experiment. 
The rats were sacrificed by an overdose of pentobarbital, the brains were dissected 
out, immediately frozen and stored at -20°C. The brain was later cut in frontal sections 
in a cryo-microtome and examined under magnification for verification of the position 
of the probe. 
Human immunocompetent cells (Papers V-VI) 
Determination of cell concentration (Papers V- VII) 
Cell concentration was determined with three different methods; (i) with a FACSort 
flow cytometer (Becton and Dickinson, San Jose', CA), (ii) with a cellcounter Cysmex 
F300 (Toa Medical Electronic Comp., Kobe, Japan), (iii) or by using a Btirker chamber 
152 
and a light microscope . 
Isolation of human cerebrospinal fluid lymphocytes (Paper V) 
CSF were prepared by centrifugation of 12 mL of CSF at lOOxg for 20 min at 4°C. 
The upper 10 mL of CSF was drawn off and used for biochemical determinations. The 
lower 2 mL was used for cell counting and analysis by CE. 
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Isolation of human CD4+ T- and B-Cell Extracts (Paper V) 
Mononuclear cells were eluted from a prostate cancer specimen after enzymatic 
digestion of the tissue as previously described153'154. T-cell clones were established by 
the limiting dilution technique155 in the presence of irradiated, autologous mononuclear 
feeder cells. Interleukin-2 (IL-2, Amersham, Bucksh, UK) and anti-CD3 antibodies 
(Ortho Diagnostics, Raritan, New Jersey, USA) were used to promote growth of the 
clones. Immunophenotyping was performed by incubation with fluorescein 
isothiocyanate (FITC)-labelled anti-CD3 (Leu-4, Becton Dickinson, Mountain View, 
CA, USA) or with FITC-labelled anti-CD4 (Leu-3a) together with phycoerythrin-
labelled anti-CD8 (Leu-2a). A Becton Dickinson FACSort flow cytometer was used 
for analysis. Cells were incubated for 1 h with a-methyl-p-tyrosine (MeTyr) or 
dopamine at 37°C with 95% relative humidity and 5% C02. B cell clones were grown 
autonomously. Extraction of catecholamines from cloned T- and B-lymphocyte 
populations were performed as later will be described in detail. 
Isolation of human peripheral blood mononuclear cells (Papers V-VI) 
Human peripheral blood mononuclear cells (PBMC) were isolated from healthy 
blood donors by centrifugation on a Ficoll-Hypaque (Sigma, St. Louis, MO, Paper V) 
or a Lymphoprep (Nycomed Pharma AS, Norway, Paper VI) density gradient, washed 
twice in PBS and resuspended in culture medium. The culture medium used 
throughout the human studies was Iscove's medium (GIBCO, Paisley, UK) 
supplemented with 10% AB, Rh+ human serum, 2 mM L-glutamine, 50 ng/mL 
gentamycin and 50 (JM mercaptoethanol. 
Murine immunocompetent cells (Paper VII) 
Isolation of murine hybridoma cells and leukocytes (Paper VII) 
The B cell hybridomas were raised and su bcloned at the Department of Clinical 
Immunology, the clone 6B9E4 was found to be specific for staphylococcal collagen 
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adhesin whereas the specificity of 4A12 is unknown. The T cell hybridomas were 
obtained from Dr. Rickard Holmdahl, Lund, hybridoma HCQ.6 is Vß 8.1+, HCQ.l 1 is 
Vß 8.2+ and HCQ.9 consists of several clones. 
To obtain macrophages 1% of sucrose in PBS was injected intraperitoneally, after 
15 min the mouse was sacrificed, the abdomen massaged and the intraperitoneal fluid 
aspirated. The cells were centrifuged at 515xg for 5 min. The pelleted cells were 
resuspended for 10 min in Tris-buffered 0.83% ammonium chloride to lyse 
erythrocytes and then washed twice in PBS. Differential counts were performed on 
May-Grünewald-Giemsa-stained smears and displayed that more than 90% of the cells 
had the morphology of macrophages. 
To obtain mononuclear cells, spleens of mice were teased and passed through a 
nylon sieve. The cells were suspended in PBS and centrifuged. Erythrocytes were 
lysed and the cells washed in PBS twice. 
Mononuclear cells of either origin mentioned above were washed once in culture 
medium and counted before the extraction procedure. Extraction of catecholamines 
from mononuclear cells was performed as later will be described in detail. 
The culture medium used throughout the murine study was Iscove's medium 
(GIBCO) supplemented with 10% FCS (Biological Ind., Beit Haemek, Israel), 2 mM 
L-glutamine, 50 pg/mL gentamycin and 50 pM mercaptoethanol (complete medium). 
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Intellektet har ett vaket öga för metoder och verktyg men är blint för mål och värden (Sài&teùi/ 
Capillary electrophoresis with laser-induced fluorescence (Papers I, 
JII-IV) 
A P/ACE 2100 instrument (Beckman Instruments; Fullerton, CA, USA) equipped 
with a P/ACE-LIF detector was used to obtain all CE separations in Papers I, III-IV. 
The LIF detector used an Ar ion laser for excitation at 488 nm (4 mW), and a 560 ± 40 
nm band-pass filter provided with the LIF detector was used to reject scattered laser 
light. Fused silica capillaries (75 pm i.d., 360 pm o.d.) were obtained from Polymicro 
Technologies (Phoenix, AZ), and all separations were performed in 57 cm lengths (50 
cm to detector) of untreated capillary. 
The buffer consisted of 50 mM borate, and 30 mM SDS was added as a 
pseudostationary phase. The pH was adjusted to 9.0 by addition of sodium hydroxide. 
The pH was measured, using a Beckman pH-meter (®32), equipped with a 
combination electrode and calibrated using a two-point calibration curve (pH 7.0-
10.0). The organic modifier dimethyl sulfoxide (DMSO) was added to this solution 
(20% DMSO v/v) to form the final separation buffer. 
The instrument was programmed to rinse the capillary with 0.1 M NaOH at high 
pressure for 2.0 min, followed by separation buffer at high pressure for 3.0 min prior to 
each injection in order to obtain consistent retention times in-between runs. Samples 
were injected automatically by pressure injection for 1.0 s (5.9 nL volume) in Papers I 
and III, or for 5.0 s (30 nL volume) in Paper IV. A separation potential of 20 kV was 
used, and the capillary was held at 25°C. The electrophoretic current was typically 33 
pA. 
The samples were kept frozen at -20°C until derivatized for CE-LIF analysis. One 
pL of internal standard, (somatostatin 3-6, 198 pM in water in Papers I and III, 
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histamine, 5 (iM in Paper IV), 5 (iL of CBQCA (3 mg/mL in MeOH) and 2 (iL KCN 
(50 mM in 50 mM borate buffer, pH 9.0) were added to 10 jiL of microdialysis sample 
in 100 (iL polycarbonate vials provided for use with the CE instrument (Beckman). 
The vial housings were filled with water and capped with the provided rubber injection 
septum in order to reduce solvent evaporation during the reaction time. Solutions were 
left to react for 2 h (Papers I and III) or 1 h (Paper IV) at room temperature before 
direct injection from the reaction vial, without prior purification of the reaction 
products. Standard solutions were made in water and derivatized under conditions 
identical to those used for CSF or microdialysis samples. In order to assure uniform 
reactivity, additional standards were derivatized in sample fluid with known amino 
acid concentrations. 
Capillary electrophoresis with UV-absorbance detection (Paper II) 
Capillary electrophoretic analysis of the anti-synaptotagmin immunoreactive 
fraction from the ^iRP-HPLC w as performed on a P/ACE 2100 instrument (Beckman 
Instruments) equipped with P/ACE-UV detection at 200 nm, and a fused silica 
capillary (75(im i.d., 360 |im o.d., length 57 cm, and length to detector 50 cm) 
(Polymicro Technologies). The separation buffer (50 mM borate, pH 9.0) contained 
50 mM SDS in order to provide a micellar pseudo stationary phase and to increase 
protein solubility. A separation potential of 10 kV was used, the electrophoretic 
current was 30 |xA, and the capillary was held at 25°C. The sample was injected 
automatically by pressure injection for 10.0 s (vol. 59 nL). 
Capillary electrophoresis with electrochemical detection (Papers V-
VII) 
The system used for CE with electrochemical detection in small bore capillaries 
was similar to that described earlier by Ewing156. In Paper V, a decoupler was used to 
allow electrical isolation of the separation potential field from the detector, but later in 
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Papers VI-VII, the system was equipped with the modified optimised end-column 
detection143 (Figure 5). Fused silica capillaries with 5-10 pm i.d. and 65-80 cm length 
were obtained from Polymicro Technologies. Electrokinetic injection was used for all 
samples, 5 s at 30 kV. The separation potential was 30 kV and the amperometric 
detection potential was 0.8 V versus a sodium-saturated calomel reference electrode. 
The electrophoresis buffer was 25 mM 2-(N-morpholino) ethanesulfonic acid (MES; 
Sigma) adjusted to pH 5.65 with NaOH. Calibration standards of 3,4-dihydroxy-L-
phenylalanine (L-DOPA), dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), 
norepinephrine (NE), 3-methoxy-4-hydroxyphenylglycol (MHPG), and uric acid (UA) 
all from Sigma, were prepared as 10 mM stock solutions in 0.1 M HC104 and diluted 
to the desired concentration in operating buffer. 
Microinjectors for capillary electrophoresis (Papers V-VII) 
A significant advance in injection of ultra-small sample volumes involved the 
construction of a microinjector from the CE capillary itself. This is accomplished by 
removing a small portion of the polyimide coating near the tip of a 5-10 pm i.d. 
capillary and etching to an o.d. of 8-10 um (Figure 5). Microinjectors are prepared by 
removing 5 mm of the polyimide polymer coating with a flame, from one end of the 
capillary to expose the fused silica. The capillary is then connected to a helium tank 
and purged with 50 psi during the etching process, which only allows some of the 
silica etching hydrofluoric acid (HF) to diffuse into the capillary tip. To etch the 
microinjector and the detector end of the capillary hydrogen fluoride is used, obtained 
as a 40% aqueous solution from Aldrich Chemicals (Steinheim, Germany). By altering 
the applied He pressure, the concentration of HF, and etching time it is possible to 
achieve the microinjector tip that best serves the experiment. After etching, the tip is 
placed into a concentrated solution of calcium carbonate to neutralize the acid and then 
washed with water. 
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The smaller tip permits viewing under a microscope as the capillary tip is 
manipulated to a specific cell. Injection of the cell is accomplished by electroosmotic 
suction which is followed by cell lysing and subsequent separation of the released 
components. A recent improvement of this technique involves etching both the outside 
and a small portion of the inside of the capillary tip to provide a conical external form 
and a funnel-like internal structure to capture the cell. This etching procedure is also 
used when constructing the optimised form of end-column electrochemical detection143 
(Figure 5), used in Papers VI-VII. 
Capillary 
SSCE reference 
electrode 
Carton fibre 
woriang electrode 
SSCE reference 
electrode 
Etched microinjector tip 
Capülary 
Ground 
Optimized end-column detection for CE 
Figure 5. Schematic drawing of the capillary electrophoretic system used for 
electrochemical detection of catecholamines. At the injection end of the capillary, a 
microinjector is etched, in order to allow analysis of single cells. At the detection end 
of the capillary an electrochemical optimised end-column detector is used. 
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Capillary electrophoretic data collection and analysis (Papers I- VII) 
Data collection at a rate of 5 Hz, processing and analysis were performed using the 
System Gold software package (Beckman). Peaks were identified by both their 
electrophoretic mobility, and by spiking samples with standard solutions of the 
analysed molecules. The analytes were subsequently quantitated using linear 
calibration plots based on peak area versus concentration. Each calibration consisted 
of at least 6 different concentrations, spanning the range of concentrations found in the 
samples. Detection limits were estimated at two times the peak to peak noise by 
extrapolation from plots of peak height versus concentration. 
In Papers I and III, somatostatin (3-6) was used as an internal standard. Two 
corresponding peaks were observed after derivatization with CBQCA, thought to be 
due to two primary amine groups in the peptide. However, the derivatization products 
are going to be further examined. Peak areas were normalised to the combined area of 
the observed peaks. Although this internal standard is not ideal, the two peaks are well 
separated from any major peaks in the CSF and microdialysis sample 
electropherograms, and the total peak area was experimentally determined to give 
consistent values over a large number of injections. In order to improve the method, 
and allow for shorter derivatizing time (from 2 h to 1 h), histamine was instead used as 
an internal standard in Paper IV. The histamine peak was experimentally determined 
to be well separated from other known substances in the separation, and the basal 
levels of histamine in brain is normally below the detection limit for the CE-LIF 
157 
assay . 
In Paper II where UV detection was used, no standard was applied since the 
synaptic vesicle protein synaptotagmin is not commercially obtainable. 
In Papers V-VII where electrochemical detection was used, catecholamines and 
their metabolites, were run as standards in-between each sample. Also, since 
electrokinetic injection was used, the injected amounts of analyte were corrected for 
injection discrimination of cations and anions. In-between series of runs, the capillary 
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was flushed with 0.1 M NaOH to refresh the inner capillary surface and to maintain 
reproducible separation conditions. 
Affinity chromatography (Paper II) 
The affinity chromatographic removal of serum proteins was performed in three 
steps: In the first step, a Blue Sepharose column (Pharmacia, Uppsala, Sweden) was 
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used for selective removal of albumin from CSF . The column was equilibrated with 
0.05 M Tris-HCl, 0.1 M KCl, pH 7.0, and 2.0 mL of CSF was loaded onto the column. 
The albumin-free CSF fraction was collected until the absorbance at 280 nm (A28o) 
was less than 0.05 arbitrary units (AU). 
In the second step, a column with staphylococcal Protein G covalently linked to 
Sepharose 4B (Pharmacia) was used for selective removal of IgG from CSF159. The 
column was equilibrated with 0.05 M Tris-HCl, 0.1 M KCl, pH 7.0, and the albumin-
free CSF fraction from step one was loaded onto the column. The albumin/IgG-free 
CSF fraction was collected until the A2g0 was less than 0.05 AU. 
In the third step, other major serum proteins were removed by loading the 
albumin/Ig-free CSF fraction onto a divinylsulfone-activated agarose column (Mini-
leak Low, Kem-En-Tec A/S, Copenhagen, Denmark) coupled with rabbit antiserum 
against human serum, cross-reacting with more than 50 serum proteins (catalogue 
#A206, Dako, Glostrup, Denmark). The column was equilibrated with 0.10 M Tris-
HCl, 0.5 M NaCl, pH 8.6, and the albumin/IgG-free CSF fraction from step two was 
loaded onto the column. The albumin/IgG/serum protein-free CSF fraction was 
collected after elution with the equilibrium buffer. Finally, the albumin/IgG/serum 
protein-free CSF fraction was vacuum dried by evaporation in a Savant Speed Vac 
Concentrator (Savant Instruments Inc., Farmingdale, NY, USA). 
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Micro-reversed phase-high performance liquid chromatography 
(Paper II) 
For separation of the CSF proteins, untreated CSF (0.5 mL), or the 
albumin/IgG/serum protein-free CSF fraction (dissolved in 500 pL of 0.14% 
trifluoroacetic acid (TFA) in ultrapure water), corresponding to 2.0 mL of untreated 
CSF, was injected into a (iRP-HPLC system (SMARTSystem™, Pharmacia), equipped 
with a nRPC C2/Clg column (dim. 2.1x100 mm, gel volume 0.35 mL, particle size 3 
Urn). The eluents consisted of 0.14% TFA in ultrapure water (eluent A) and 0.12% 
TFA in 60% acetonitrile (eluent B). Elution was achieved with isocratic elution (46% 
B) in 10 min, two linear gradients of 46-83% B in 30 min and 83-100% B in 5 min 
respectively, and finally with isocratic elution (100% B) in 5 min with a flow rate of 
200 n.L/min. The eluent after the void volume was collected in 40 fractions of 150 |oL, 
which thereafter were vacuum dried. 
Electrospray ionisation mass spectrometry (Paper II) 
The fractions from the (iRP-HPLC containing the major peaks were analysed by 
electrospray ionisation mass spectrometry (VG BIO-Q, Fisons, Loughborough, UK.) to 
determine the molecular weights of ß2-microglobulin, prealbumin, cystatin C and 
asialotransferrin. 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (Papers 
II, VI) 
Samples subjected for SDS-PAGE were dissolved in sample buffer (0.08 M Tris-
HC1, pH 6.8, containing 0.17 M SDS, 6.5 mM dithiothreitol (DTT), 0.5 M urea, and 
0.1% bromphenol blue), ultrasonicated for 15 min, and boiled for 5 min. The proteins 
were separated on a 12% Polyacrylamide gel (Ready Gels, BioRad, Richmond, CA). 
46 
5. Methods 
The electrophoresis was run for 30 min at 200 V constant voltage in a Mini-
PROTEAN11 Cell (BioRad, Richmond, CA), using the buffer systems of Laemmli160. 
Western blotting of brain specific proteins (Paper II) 
For Western blotting of the albumin/IgG/serum protein-free CSF fractions 
separated by |iRP-HPLC, the proteins in the SDS-PAGE gel were transferred from the 
gel onto a polyvinyl difluoride (PVDF) membrane (Millipore, Bedford, MA, USA), by 
the semidry technique using the Multiphor II NovaBlot Unit (Pharmacia) at 0.8 
mA/cm2 for 30 min. After blotting, the PVDF membrane was blocked with 5% non-
fatty milk powder in phosphate buffered saline (PBS, 58 mM Na2HP04, 17 mM 
Na2HP04xH20, 68 mM NaCl, pH 7.4), containing 0.05% Tween 20. After that, the 
PVDF membrane was incubated with specific antiserum against human ß2-
microglobulin161, cystatin C162, prealbumin163' I64, and transferrin165, all from Dako 
(Glostrup, Denmark). After incubation with the secondary alkaline phosphatase 
conjugated goat anti-rabbit IgG (Jackson, West Grove, PA), the colour reaction was 
developed with 0.015% 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and 0.030% 
nitro-blue tetrazolium (NBT), both from Sigma, in 0.1 M carbonate buffer containing 
1.0 mM MgCl2166. 
Enhanced chemiluminescence (ECL) immunoblotting (Paper II) 
For ECL immunoblotting of the synaptic vesicle specific proteins in the 
albumin/IgG/serum protein-free CSF fractions separated by jiRP-HPLC, the proteins 
in the SDS-PAGE gel were transferred from the gel onto a Hybond nitro-cellulose 
membrane, blocked with 5% milk powder in 0.05% PBS-Tween, and then incubated 
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with the specific MAbs against synaptophysin (CI. 7.2) , diluted 1:500, 
synaptotagmin I (CI. 41.1)168"170 diluted 1:500, or rab3a protein (Cl. 42.2)171 diluted 
1:500, all in PBS-Tween. The membrane was incubated for 1 h with alkaline 
phosphatase conjugated goat anti-mouse IgG+M (H+L, Jackson) diluted 1:4000. 
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Detection was performed using ECL (Amersham), according to the manufacturers 
instructions. 
Quantitative Western blotting of synaptotagmin in brain tissue 
(Paper II) 
Samples of homogenised brain tissue (« 100 mg wet weight) were delipidised in 
chloroform/methanol/water (4/8/3, v/v)172, and centrifiiged at 2000xg for 10 min. The 
pellet was resuspended in chloroform/methanol/water, centrifuged, and the supernatant 
containing the lipids was discarded. After that, the pellet was dried under a stream of 
nitrogen, dissolved in SDS sample buffer, and subjected to SDS-PAGE and Western 
blotting to a PVDF membrane, as described above, using the anti-synaptotagmin MAb. 
The total protein concentration was determined in each sample using the bicinchoninic 
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acid method , and the volume of each sample was adjusted to get a total protein 
concentration of 5 (ig/mL. A volume of 20 (iL (corresponding to 100 ng of total 
protein) was loaded onto the gel. 
Synaptotagmin was quantified by scanning of the PVDF membrane on a Camag 
Scanner II (Mattenz, Switzerland) at 620 nm. In order to make a standard curve, 
hippocampal or frontal cortex brain homogenate from one control case was prepared as 
described above, and three dilutions (2.5, 5.0, and 10.0 ng/mL total protein) of the 
standards were run on each gel. The synaptotagmin level in the 5.0 jig/mL 
hippocampal and frontal cortex standards (corresponding to 100 ng of total protein) 
was set as 1 AU, and after that, all values were corrected by dividing with the mean 
band intensity in controls in hippocampus and frontal cortex respectively. 
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High performance liquid chromatography for detection of amino 
acids (Paper III) 
The system employed for the analysis of GABA consisted of a high-pressure pump 
(Knauer 64) connected to a CMA/200 refrigerated microsampler (Carnegie Medicin, 
Stockholm, Sweden) working at 4°C, an on line CMA 260 degasser, and a Spectra 
Physics 4290 integrator174. The derivatization reagent used for the electrochemical 
detection of GABA was prepared by dissolving 27 mg of o-phthaldialdehyde in 10 mL 
of 0.1 M carbonate buffer, pH 9.6, containing 50% methanol and 45 |iL of t-butylthiol. 
A robotics program was set to add 0.5 (iL of the reagent to 20 (iL of standard or 
dialysis sample. The reagent was mixed with the sample three times and, after 120 s, 
20 (iL were injected onto the column. The 100x4 mm column, packed with Nucleosil-
3 (particle size 3 (am) C18 (Knauer, Berlin, Germany), was equipped with a 5x4 mm 
guard column packed with the same material but of 5 |j.m particle size. The mobile 
phase was 0.15 M sodium acetate buffer, 1 mM EDTA (pH 5.4), and 50% acetonitrile 
at a flow rate of 0.8 mL/min. An electrochemical detector, BAS LC4C (Bioanalytical 
Systems, West Lafayette, IN, USA) set at 80 nA was used, with the glassy carbon 
working electrodes set at + 0.75 V. Analysis time was 8-10 min per sample. External 
standards or blanks (water) were injected following every fourth sample to confirm the 
reliability and selectivity of the derivatization. GABA was detected 3 min after 
injection. In addition, a standard curve ranging from 1 nM to 1000 nM was 
constructed and observed to be linear. The detection limit for GABA was 
approximately 0.5 nM at an injection volume of 10 p.L. 
The assay of glutamate started with a pre-column derivatization with o-
175 pthaldialdehyde/mercaptoethanol reagents followed by fluorometric detection . 
Briefly, 10 (iL of reagent (0.4 M borate, 0.04 M o-pthaldialdehyde, 0.4 M 
mercaptoethanol, pH 10.4) was added to 10 \xL of the perfusate and following 60 s 
reaction time, 15 ^L of the derivatized aliquot was injected into the column. The 
system consisted of a cartridge column (i.d. 4 mm; length 60 mm) containing 5 (im 
Nucleosil-100 C18 packing material (Knauer), a Spectra Physics 8800 ternary precision 
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pump with a two way valve (Spectra Physics, San Jose, CA, USA), an on line CMA 
260 degasser and a Spectra Physics 4220 integrator. The system used a Hitachi F1000 
fluorescence spectrophotometer (Hitachi, Tokyo, Japan) with the excitation 
wavelength set at 370 nm and emission cut-off at 450 nm for detection. The mobile 
phase was 0.1 M sodium acetate with 8% (v/v) methanol and 1.5% (v/v) of 
tetrahydrofuran adjusted to pH 6.95. The flow rate was 1 mL/min. A multilinear 
gradient (100% mobile phase to 100% methanol in 6 min, returning to 100% mobile 
phase after 2 min) was used to clean the column after glutamate elution. An integrator 
(SP 4220, Spectra-Physics, San Jose, CA, USA) was used to determine concentrations 
of glutamate. The integrator was calibrated with a 1.875 |iM solution of 32 amino 
acids, and the limit of detection for glutamate was 100 nM at a sample volume of 10 
pL. 
High performance liquid chromatography for detection of morphine 
(Paper IV) 
An automated ion-pair HPLC-system with electrochemical detection was used for 
morphine quantification176. Ten \ih of the dialysis sample was diluted (1:10) with 
perfusion medium and further diluted (1:10) with mobile phase prior to injection into 
the chromatographic system. 
Immunological cell assays (Papers V-VII) 
Proliferative responses of lymphocytes (Papers V-VII) 
Proliferation and differentiation of human peripheral blood mononuclear cells 
(PBMC) were induced by mitogen stimulation. PBMC were incubated with 25 ng/mL 
of Con A or 10 ng/mL of Pokeweed mitogen (PWM) (GIBCO) for T- and B-cell 
stimulation, respectively. In proliferation assays PBMC were incubated at a 
concentration of lxlO6 mononuclear cells/mL in 96-well flat-bottomed microtitre 
plates (Nunc, Roskilde, Denmark) in 0.1 mL culture medium at 37°C in 5 % CO2 and 
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95 % humidity. To the PBMC cultures were added 0-500 jiM of L-DOPA, DA or NE, 
all compounds obtained from Sigma. The cells were either preincubated with the 
respective compounds at 37°C for 2 h, then washed, recounted and resuspended in 
culture medium, before stimulation with mitogens, or cultured together with the 
respective compounds throughout the mitogen stimulation. The cells were cultured for 
72 h. During the final 18 h of culture 1 (iCi 3H-thymidine (Radiochemical Centre, 
Amersham) was included in each well. The cultures were harvested on glass fibre 
filters, processed and counted in a ß-counter. The cultures were set up in triplicate and 
results expressed as percentage of control mean counts/min. 
Mouse spleen mononuclear cells were incubated at a concentration of lxlO6 
mononuclear cells/mL in 96-well flat-bottomed microtitre plates (Nunc) in 0.1 mL 
complete medium at 37°C in 5% C02 and 95% humidity. Tyrosine, L-DOPA, DA and 
NE in concentrations ranging from 0-500 |iM and Con A (Miles Yeda, Rehovot, 
Israel) or LPS (Sigma) were included in the medium. The cells were cultured for 48-
72 h which was previously found to be the optimal culture time177. During the final 8-
18 h of culture, 1 (iCi 3H-labelled thymidine (Radiochemical Centre) was included in 
each well. The cultures were harvested, processed and counted as above. Preliminary 
experiments showed that for murine cells, the optimal proliferative responses to Con A 
and LPS were obtained using 2.5 (ig/mL and 10 ng/mL of the stimulants, respectively. 
Differentiation of immunocompetent cells (Papers V- VII) 
In differentiation assays human peripheral blood mononuclear cells and murine 
splenocytes were stimulated with mitogens in 1 mL culture medium. Supernatant 
from stimulated cell cultures, were harvested, and analysed for IL-4 and IFN-y (Papers 
V-VI) or IL-2, IL-6 and IFN-y (Paper VII) production. The cytokine levels in 
supernatants were determined by bioassays (using indicator cells for IL-2 and IL-6) or 
by enzyme-linked immunosorbent assays (ELISA, see below). The ELISPOT 
technique31 was used to determine the numbers of immunoglobulin secreting cells of a 
given isotype (see below). 
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IL-2 assay (Paper VII) 
Supernatants from murine splenocytes cultured for 24 h with Con A were analysed 
for the content of IL-2 using the CTLL-2 cell line178. The particular CTLL-2 line used 
was chosen because it does not proliferate in response to recombinant IL-4 and thus 
provides a selective assay for IL-2179. Indicator cells were cultured in supernatants for 
24 h and 3H-labelled thymidine was included during the last 4 h of culture. IL-2 
activity was determined in triplicate cultures and expressed as mean counts/min of 3H 
uptake by CTLL-2 cells. In each experiment a standard IL-2 curve was generated 
using mouse recombinant IL-2 (Genzyme, Cambridge, MA) and the IL-2 content of 
the supernatant was calculated from the linear part of the standard curve. 
IL-4 assay (Paper VI) 
To determine IL-4 levels, 96-well plates (MAXISORP, Nunc) were coated 
overnight at 4°C with 50 |aL (2 ng/mL, diluted in 0.1 M carbonate buffer pH 9.6) of 
monoclonal anti-human IL-4 antibody (MABTECH, Stockholm, Sweden). The coated 
plates were washed with 0.05 M Tris-HCl (pH 7.4) + 0.05% Tween 20 and saturated 
with 100 pL 1% BSA in 0.05 M Tris-HCl for 1 h at room temperature. After washing, 
the plates were incubated for 2 h at 37°C with different samples (50 pL/well), followed 
by further washes. Biotinylated anti-human IL-4 (MABTECH, 50 pL, 2 ^ig/mL in 
0.05 M Tris-HCl + 0.015 M NaCl) was added and incubated overnight at 4°C. The 
plates were washed again and re-incubated with 50 pL (4 (ig/mL) of StreptAvidin 
Alkaline Phosphatase (Sigma) for 1 h at room temperature, followed by thorough 
washes. The enzyme substrate (p-nitrophenyl-phosphate (Sigma), 1 mg/mL in 100 pL 
diethanolamine buffer) was then added and optical density at 405 nm was determined 
in a Titertek Multiscan photometer (Flow Laboratories). The concentration of the IL-4 
was calculated using standard curve based on known quantities of recombinant human 
IL-4 (Genzyme). The samples were assayed in triplicate and results expressed as 
percentage of control IL-4 production. 
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IL-6 assay (Paper VII) 
Cell line B 13.29, which is dependent on interleukin-6 (IL-6) for growth, has been 
previously described180. For IL-6 determinations, the more sensitive subclone B9 was 
used181'182. B9 cells were harvested from tissue culture flasks, seeded into microtitre 
plates (Nunc) at a concentration of 5000 cells per well, and cultured in complete 
Iscove's medium with supernatants from splenocytes cultured for 24 h with Con A or 
for 48 h with LPS. After 68 h of culture 3H-labelled thymidine was added and the cells 
were harvested 4 h later. The samples were tested in twofold dilutions and compared 
183 
with an recombinant mouse IL-6 standard (Genzyme) . B9 cells were previously 
shown not to react with several recombinant cytokines, including IL-la, IL-lß, IL-2, 
IL-3, IL-5, granulocyte-macrophage colony-stimulating factor, TNF-a and IFN-y. 
182 There was only weak reactivity with IL-4 
IFN-y assay (Papers V- VII) 
When determining IFN-y production in human peripheral blood mononuclear cells, 
96-well plates (MAXISORP, Nunc) were coated overnight at 4°C with 50 (iL (5 
Hg/mL, diluted in 0.1 M carbonate buffer pH 9.6) of monoclonal anti-human IFN-y 
antibody (Kabi Diagnostica AB, Mölndal, Sweden). The coated plates were washed 
with 0.05 M Tris-HCl (pH 7.4) + 0.05% Tween 20, and saturated with 100 (iL 1% 
BSA in 0.05 M Tris-HCl (pH 7.4) for 1 h at 37°C. After washing, the plates were 
incubated for 2 h at 37°C with different samples diluted in PBS (50 |xL/well), followed 
by further washes. Biotinylated anti-human IFN-y (Kabi Diagnostica AB, 50 (iL, 1.2 
(ig/mL) was added and incubated overnight at 4°C. The plates were washed again and 
re-incubated with 50 |iL (4 ng/mL) of ExtraAvidin Alkaline Phosphatase (Sigma) in 
0.05 M Tris-HCl (pH 7.4) + 0.015 M NaCl for 1 h at room temperature, followed by 
thorough washes. The enzyme substrate (p-nitrophenyl-phosphate (Sigma), 1 mg/mL 
in 100 [iL diethanolamine buffer) was then added and optical density at 405 nm was 
determined in a Titertek Multiscan photometer (Flow Laboratories). The concentration 
of the IFN-y was calculated using standard curve based on known quantities of 
53 
5. Methods 
recombinant human IFN-y (Genzyme). The samples were assayed in triplicate and 
results expressed as percentage of control IFN-y production. 
When determining IFN-y production in murine cells, polystyrene flat-bottomed 
plates were coated overnight at 4°C with 2 jig/mL of purified anti-mouse IFN-y 
(PharMingen, San Diego, CA). The coated plates were washed and saturated with 1% 
BSA for 1 h at 37°C. After washing, the plates were incubated for 2 h at 37°C with 
different dilutions of samples. Biotinylated anti-mouse IFN-y (PharMingen) (2 
Hg/mL) was added and incubated overnight at 4°C. The plates were washed again and 
re-incubated with 4 (ig/mL of ExtrAvidin Alkaline Phosphatase (Sigma). The enzyme 
substrate was then added and optical density was determined in a Titertek Multiscan 
photometer (Flow Laboratories, McLean, VA). The concentration of the IFN-y was 
calculated using standard curve based on known quantities of recombinant mouse IFN-
y (Genzyme). 
Immunoglobulin assay (Papers V- VII) 
Number of immunoglobulin producing cells, was determined by the enzyme-
linked immunospot assay (ELISPOT). Briefly, wells in the lids of 24 well culture 
cluster plates (Costar, Cambridge, MA) were coated overnight at 4°C with affinity-
purified F(ab')2 fragments of goat anti-human or goat anti-mouse IgG and IgM 
(Cappel, Cochraneville, PA) at a concentration of 5 ng/mL. The plates were then 
washed with tap water and blocked with 5% FCS in PBS for 1 h. Mononuclear cells 
from the mitogen stimulation assay were washed and viability was assessed by trypan 
blue. One hundred \iL of mononuclear cells resuspended in Iscove's complete 
medium was added into each coated well and incubated for 3.5 hours at 37°C. After 
another wash, affinity-purified biotinylated F(ab')2 fragments of goat anti-human or 
goat anti-mouse IgG or IgM antibodies (Jackson), diluted 1:750 in PBS containing 
0.05% Tween 20 were applied followed by incubation with 0.5 ng/mL of ExtrAvidin-
alkaline phosphatase (Sigma) in PBS-Tween. After addition of the phosphatase 
substrate solution (BCIP; Sigma) spots were enumerated under low magnification. 
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Each spot represents one immunoglobulin producing cell (spot forming cell). All the 
assays were done in duplicates and at cell concentrations of lxlO4, lxlO5, lxlO6 
cells/mL for the IgG spots and lxlO3, lxlO4 and lxlO5 cells/mL for the IgM spots. 
Incubation of human peripheral blood mononuclear cells, murine hybridoma 
cells and splenocytes with the tyrosine hydroxylase inhibitor u-methyl-p-
tyrosine (Papers V, VII) 
Catecholamine production by PBMC, HCQ.6 hybridoma cells and splenocytes 
was blocked by the tyrosine hydroxylase inhibitor a-methyl-p-tyrosine (MeTyr). 
Cells were incubated for 1 h with 10 (xM of MeTyr, L-DOPA and DA respectively in 
complete medium at 37°C. The cells were washed, recounted and the catecholamines 
were extracted as described below. In proliferation assays spleen cells were incubated 
with 10 |iM MeTyr for 1 h, washed and stimulated with Con A or LPS, or incubated 
with 10 |iM MeTyr over night before Con A and LPS was added. 
Incubation of human peripheral blood mononuclear cells with dopamine uptake 
and storage blockers (Paper VI) 
The effects of nomifensine maleate (Hoecht-Roussel Pharmaceuticals, Somerville, 
NJ) and tetrabenazine (Fluka AG, Switzerland) were examined by incubating isolated 
PBMC (lxlO6 cells per sample) with 10 pM DA or 10 pM DA in combination with 10 
pM nomifensine or 10 ^M tetrabenazine, respectively for 1 h at 37°C. The cells were 
then washed twice in PBS and extracted as described below. 
Extraction of catecholamines from human and murine mononuclear cells 
(Papers V-VII) 
The cells were washed twice in PBS and extracted by addition of 10 pL of 0.1 M 
perchloric acid with 1 mM sodium EDTA and 1 mM sodium sulphite to the cell pellet 
in an Eppendorf tube, to end up at a total volume of 15 pL. This was ultrasonicated for 
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1 min on ice using a MSE Soniprep 150 probe, and the extract was centrifuged for 30 
min (35000xg) at 4°C. All samples were prepared and analysed in triplicate. 
Induction and detection of apoptosis in human mononuclear cells and murine 
splenocytes (Papers VI- VII) 
Human PBMC, IL-2 dependent human lymphoid cell clone (CTLL-2)178 and 
murine splenocytes, lxlO6 mononuclear cells/well, were incubated in 96-well flat-
bottomed microtitre plates with 0-500 pM of L-DOPA, DA or NE in a total volume of 
0.1 mL at 37°C. The cells were either treated for 24-72 h followed by 2 washes in PBS 
or pre-treated for 4 h in 37°C, washed twice, incubated for 24-72 h and rewashed. 
Cells were stained with propidium iodide in a hypotonic staining solution184 with 0.1 
mg/mL of RNAse added and propidium iodide fluorescence of individual nuclei was 
measured on a FACSort flow cytometer with a Lysys II software program (Becton and 
Dickinson, San Jose', CA). All samples were prepared and analysed in triplicate and 
data expressed as percent apoptotic (i.e. hypodiploid) nuclei. 
The analysis of Bcl-2/Bax and Fas/FasL expression in control and catecholamine 
induced apoptotic human PBMCs was performed by western blotting (see below), 
using antibodies purchased from Santa Cruz Biotechnology (CA). 
Western blot for analysis of apoptotic markers (Paper VI) 
For Western blotting of the apoptotic regulatory proteins (Bcl-2, Bax, Fas and 
FasL), the proteins separated in a SDS-PAGE gel were transferred from the gel onto a 
polyvinyl difluoride (PVDF) membrane (Millipore, Bedford, MA, USA), by the 
semidry technique using the Multiphor II NovaBlot Unit (Pharmacia) at 0.8 mA/cm2 
for 30 min. After blotting, the PVDF membrane was blocked with 5% non-fatty milk 
powder in PBS, containing 0.05% Tween 20 for 1 h. After that, the PVDF membrane 
was incubated with specific antiserum against the different apoptotic regulatory 
proteins Bcl-2 (mouse monoclonal IgG from Santa Cruz Biotechnology, CA), Bax, 
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Fas, FasL (all rabbit polyclonal IgG from Santa Cruz Biotechnology, CA), in di lution 
1:1000 over night. After incubation with the secondary alkaline phosphatase 
conjugated goat anti-mouse IgG (1:2000, Jackson) for 2 h or the biotinylated goat anti-
rabbit IgG (1:4000, Jackson) for 1 h, followed by alkaline phosphatase conjugated 
ExtrAvidin (1:4000, Sigma) for 1 h, the colour reaction was developed with 0.015% 
BCIP (Sigma) and 0.030% NBT (Sigma) in 0.1 M carbonate buffer containing 1.0 mM 
MgCl2166. 
Statistics (Papers I-VII) 
In Papers I, V-VII the level of significance of the differences between groups was 
calculated using a paired Students two-tailed /-test. In Paper II the level of 
significance of the differences between groups was calculated using the Mann-Whitney 
U-test, and the Spearman correlation coefficient was used for correlations. In Papers 
185 III and IV, the Friedman nonparametric ANOVA was used, followed by either 
• 186 pairwise comparisons, Dunnetts test, or unpaired t-test. 
Values are presented as mean ± standard error of the mean (mean ± SEM) unless 
otherwise indicated. 
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6. Summary of the results and their implications 
Egentligen vet man något först när man nästan inget vet. Tvivlet växer med 
kunskaperna 
^vAasisv Wofåpvuy von 
CE-LIF detection of amino acids in human cerebrospinal ßuid (Paper I) 
A rapid and simple procedure for analysis of amino acids in human CSF was 
developed. Capillary electropherograms containing more than 50 peaks were obtained 
in less than 40 min from 10 pL samples of unconcentrated human CSF. Many of these 
peaks, including arginine, glutamine, threonine, valine, GABA, serine, alanine, 
glycine, glutamic, and aspartic acid, were identified and quantitated. Capillary 
electropherograms obtained from patients with Alzheimer's disease, and from children 
with various neurological disorders, were compared to healthy controls. The CSF from 
patients and healthy controls revealed significant differences. For example, GABA 
levels were decreased in CSF samples from Alzheimer patients, while glutamic and 
aspartic acid levels were decreased in CSF samples from children compared to the CSF 
samples from elderly patients. 
These results indicate that CE with laser-induced fluorescence detection has a 
significant potential as a tool in the evaluation of disorders related to the CNS. 
Isolation, identification and analysis of synaptotagmin in human cerebrospinal 
fluid (Paper II) 
With the use of affinity chromatography, reversed-phase chromatography, and 
chemiluminescence immunoblotting of human CSF, the synaptic vesicle protein, 
synaptotagmin I, was isolated, identified, and quantitated. By using the 
chromatographic procedures mentioned above, enrichment of CSF proteins was 
accomplished, an approach that may be applied to many brain-specific proteins. CE 
with UV-detection, with its high resolving power and large peak capacity, was used to 
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further chromatographically characterize the isolated anti-synaptotagmin reactive 
protein fraction. Only one peak was found in the electropherogram, which showed the 
homogeneity of the isolated fraction. A lower concentration of synaptotagmin in CSF 
samples from patients with early-onset Alzheimer's (EAD) was demonstrated. Results 
showing a decrease of this protein in the hippocampus and frontal cortex from EAD 
patients support that pathological events in the brain involving this protein, are likely 
to be reflected in the CSF. 
CE-LIF detection of amino acids in microdialysis samples of rat periaqueductal 
grey (PAG) matter (Papers III-IV) 
In the electropherograms obtained from the CE-LIF system, over 30 shoulders and 
peaks were detected in 20 min. Among these peaks, 8 amino acids were identified and 
quantified (arginine, glutamine, valine, GABA, alanine, glycine, glutamate, and 
aspartate). GABA and glutamate were also analysed with HPLC in order to be able to 
compare with the CE results. A good correlation between the two methods was found. 
The results of the present study indicate that CE can be used for the detection of amino 
acids in microdialysis samples of the rat brain. Among the amino acids analysed, the 
potassium induced release of GABA was found to be calcium dependent, while 
significant decreases in glutamine and valine levels after the potassium stimulation 
were found, the latter being under calcium free conditions. 
Considering the low detection limit and the low volume needed for detection of 
GABA by the CE assay, this method together with microdialysis, seems to be 
especially useful for the detection of fast and transient changes of extracellular 
transmitter levels. 
The capillary electrophoretic method developed in Paper III was, with some minor 
modifications (see Methods), used in Paper IV to study the effect of morphine on the 
GABA release in the PAG of freely moving rats. The basal GABA level was 
significantly decreased after perfusion of the dialysis probe with morphine for 30 min. 
The effect of morphine was reversed by co-perfusion with naloxone. The present 
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results thus provide direct experimental evidence for an opioid induced inhibition of a 
tonic GABA release in the PAG, which may in turn lead to a disinhibition of 
descending pain inhibitory pathways. 
CE analysis of single human lymphocytes from cerebrospinal fluid (Paper V) 
The analysis by CE of single lymphocytes, isolated from human CSF, has led to 
the discovery that these cells contain catecholamines. The electropherogram in Figure 
6 shows the analysis of one single human lymphocyte with a volume of-180 fL. The 
cell was injected into an etched 10 jam i.d. capillary by electroosmotic flow. After 
lysing the cell, a potential of 25 kV was applied to separate and mobilise the 
cytoplasmic components towards the electrochemical detector. The cationic peak at 
10.8 min (peak 1) was tentatively identified as DA, based on electrophoretic mobility, 
and an average DA content of 2.3 ± 1.7 attomoles (mean±SEM, n=3) was found for 
CSF lymphocytes. Peak 1 might also have contained other electroactive amines with 
similar electrophoretic mobilities such as NE, epinephrine, or serotonin. However, the 
electrophoretic mobility of peak 4 corresponds to dihydroxyphenylacetic acid 
(DOPAC), a metabolite of DA, which strongly suggested that peak 1 contained DA. 
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Figure 6. Electropherogram of a single human CSF lymphocyte. Conditions were 
as follows: separation capillary 10 |xm i.d, 80 cm length with decoupler156 ; buffer, 25 
mM MES (pH 5.65); injection, 60 s at 1 kV to draw the lymphocyte into the capillary 
tip followed by a 15 s injection of digitonin to permeabilize the cell; separation 
potential, 25 kV; amperometric detection potential, 0.8 V vs a sodium-saturated 
calomel reference electrode. Electrophoretic mobilities of the major peaks correspond 
to the calculated electrophoretic mobilities of dopamine (peak 1), a neutral species 
(peak 2), uric acid (peak 3), and DOP AC (peak 4). (Reproduced with permission from 
Proc. Natl. Acad. Sei. USA). 
CE of single cloned human lymphocytes (Paper V) 
Single cloned CD4+ T lymphocytes and B lymphocytes have been examined by 
CE and found to contain catecholamines. Cloned CD4+ T lymphocytes were found to 
hold catecholamines at a level of 31 ± 29 attomoles (mean ± SEM, n=3), while a single 
B lymphocyte was found to contain 310 zeptomoles of catecholamines. 
CE analysis of catecholamines in immunocompetent cells (Papers V- VII) 
The levels of catecholamines have also been quantitated in extracts from cloned 
human CD4+ T lymphocyte populations, and found to be 1.8 ± 1.0 attomoles per cell 
(mean ± SEM, n=13), within the range of catecholamine levels found in single CD4+ T 
cells (Paper V). The average catecholamine level in extracts of cloned B cells was 2.0 
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±1.5  a t tomoles  pe r  ce l l  (mean  ±  SEM,  n=3) .  Us ing  a  modi f i ed  ana ly t i ca l  se t -up ,  the  
DA and the NE peak could be separated based on electrophoretic mobility, and freshly 
isolated PBMC were found to hold 1.61 ± 0.72 attomoles of DA per cell, while the 
basal NE levels were 0.96 ± 0.86 attomoles/cell (mean ± SEM, n=3) (Paper VI). In 
these separations, not only the main metabolite of DA (i.e. DOP AC) was detected, but 
also a peak corresponding to the main metabolite of NE, i.e. 3-methoxy-4-
hydroxyphenylglycol (MHPG) was detected, strongly suggesting the presence of both 
DA and NE in these cells (Figure 7.) 
Figure 7. Separation and detection of easily oxidized species in microextracts of 
isolated human peripheral blood mononuclear cells by CE. Conditions: separation 
capillary, 10 \xm i.d ., 65 cm length with optimized end-column detection'43; buffer, 25 
mM MES (pH 5.65); injection was 5 s at 30 kV; separation potential, 30 kV; 
amperometric detection potential, 0.8 V vs a sodium saturated calomel reference 
electrode. The electrophoretic mobilities of the major peaks shown correspond to the 
calculated electrophoretic mobilities of dopamine (DA), norepinephrine (NE), a 
neutral species (N), 3-methoxy-4-hydroxyphenylglycol (MHPG), uric acid (UA), 3,4-
dihydroxyphenylacetic acid (DOPAC). (Reproducedfrom Paper VI). 
Furthermore, the catecholamine levels in mouse spleen cells, in peritoneal 
macrophages, and in T- and B-cell hybridomas were determined with CE (Paper VII). 
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The spleen cells contained 66 ± 57 attomoles of DA and 23 ± 12 attomoles of NE per 
cell, while the peritoneal macrophages contained 20 ± 18 attomoles of DA and no 
detectable amounts of NE (mean ± SEM, n=3). The variation among different 
hybridoma cell clones was found to be notable, ranging from 1.9 ± 0.7 attomoles of 
DA/cell down to below the detection limit (approximately 100 zmol). Also the NE 
levels varied from 280 ± 80 zeptomoles/cell down to undetectable levels. In order to 
examine the uptake and biosynthesis of catecholamines in lymphocytes, both human 
and murine T cell clones were incubated with either DA, or the DA synthesis inhibitor 
a-methyl-p-tyrosine (MeTyr, Papers V, VII). After incubation with DA or L-DOPA 
(the precursor to DA), a large increase in the level of DA per cell was observed. 
However, incubation with the synthesis inhibitor decreased the level of DA. Further, 
the uptake of DA into PBMC was significantly decreased (pO.Ol) by co-incubating 
the cells with nomifensine187, a DA transporter antagonist (Paper VI). The 
188 
corresponding incubation with DA in the presence of, tetrabenazine , a 
catecholamine storage blocker, led to similar results, with a significant decrease of 
intracellular catecholamines (p<0.05). None of these substances affected the basal 
levels of catecholamines in PBMCs. 
Analysis of catecholamine induced apoptosis in immunocompetent cells (Papers 
VI-VII) 
The possible ability of catecholamines to suppress lymphocyte proliferation and 
differentiation by triggering of apoptosis, was assayed by two different methods. First, 
the DNA damage in cells after incubation with L-DOPA, DA and NE was assessed by 
measuring of an intercalating fluorescent agent in a flow cytometer. Apoptosis was 
dose-dependently induced, both in human PBMC and in murine spleen cells. Second, 
a dose-dependent decrease of the apoptosis inhibitor protein Bcl-2, and dose-dependent 
increase of the apoptosis inducing proteins Bax, Fas and FasL were determined by 
western blotting. 
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Methodological aspects 
CE is becoming accepted as a new separation technique, that is and will be of great 
importance in bioanalytical chemistry. There are many characteristics of CE, some of 
them are listed in Table 1. 
Table 1. Characteristics of CE 
• Capillary electrophoresis is performed in narrow-bore (2 to 200 |im i.d.) fused silica capillaries 
• High voltages (5 to 40 kV) and high electric fields (100 to 500 V/cm) are applied across the 
capillary 
• High efficiency (N>105 to 106) and short analysis time 
• High peak capacity (can separate 10 times more substances, with 10 times higher selectivity 
compared with HPLC) 
• Numerous modes to vary selectivity and wide application range 
• Numerous modes of detection, performed on-column 
• Small sample volume required (10"'3 to 10"' L injected) 
• Consumes limited quantities of reagents 
• Operates in aqueous media 
Many parameters in CE can be altered however, and will consequently influence 
on the efficiency, resolution, and selectivity of the method. Some of these aspects 
have been mentioned in the introduction (see Principles of CE). Briefly, there is a 
number of practical things to consider when constructing a separation method for CE. 
Some of these are listed in Table 2. 
Table 2. Variables in CE 
• Capillary length 
• Capillary diameter and wall coatings 
• Detection method to use 
• Applied field strength 
• Temperature control 
• Ionic strength of the separation buffer and in the sample 
• The pH of the separation buffer 
• Additives and organic modifiers in the separation buffer 
• Injection mode 
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Since many factors are involved during the electrophoretic separation, 
reproducibility and quantification may in some cases be problematic. Difficulty in 
maintaining a constant temperature inside the capillary, viscosity changes, pH 
variations, ion depletion in the buffer reservoirs, binding of sample molecules to the 
capillary wall etc., may all affect the electroosmotic flow and in turn make 
identification and quantification elaborate. Furthermore, since one of the major 
advantages with CE is the possibility to handle small sample volumes and analysis of 
extremely low amounts (down to single molecules), one needs to consider problems 
associated with evaporation and contamination. Also, working with complex 
biological systems may introduce problems due to sample instabilities. 
In order to minimise these analytical problems it is important to control a number 
of parameters, some of them listed in Table 3. 
Table 3. Parameters to consider to achieve good results in CE 
• Attend to effective temperature control, especially important in capillaries with >25 (im i.d., since 
internal heating could dramatically effect the separation 
• Use low heat producing buffers 
• Regenerate buffers frequently (in-between every 10 runs, depending on reservoir size) 
• Regenerate the capillary wall with base or acid in-between runs 
• Compensate for mobility changes by using internal standards (also important in derivatization 
procedures to control the degree of reaction equilibrium established) 
• Ensure a correct identification by spiking samples with known amounts of standards or by 
blocking with known synthesis inhibitors 
• Seal and store samples cold in order to reduce evaporation 
• Eliminate the risk of contamination, by running blank runs of buffers, medium, etc. 
• Consider the sampling procedure and sample treatment 
Finally, the interpretation of data obtained from the electropherogram, is of great 
importance. Here, the use of a chromatography software is of help, by keeping track of 
current, voltage, capillary dimensions and other experimental parameters. The 
software can provide actual peak migration time, corrected peak migration time, peak 
height, and the peak area. It can calculate the electrophoretic mobility for a given peak 
and also calculate concentrations based on peak height or peak area. 
By controlling all of the above parameters, CE fulfils all the requirements for a 
valid and reliable analytical tool. 
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Discussion of results 
In our first paper the major objective was to show the capability of the CE-LIF 
technique for the direct analysis of amino acids in a biological fluid as CSF, without 
prior purification. Clearly, it emphasises the advantages of the separation and 
sampling capabilities of CE, and the sensitivity of the LIF detection. The separation 
conditions and derivatizing procedures were optimized in order to determine GABA 
levels. GABA is a very challenging neurotransmitter to assay due to its low 
concentration and instability. The procedure used for the GABA determination gave a 
rather large variation in detection limits for the other amino acids. Plausible 
explanations are that there are varied amounts of individual amino acids available, and 
that they have differing steric conformations. These differences in properties, will 
result in heterogeneous derivatizing reaction times for individual amino acids. It is 
also possible that amino acids interact to different degrees with other molecules in the 
sample, e.g. proteins. The recovery data presented in P apers I and III, to some extent 
suggest this phenomenon. 
Derivatization times between 5 min and 7 h were tested. Two hours was chosen 
because the GABA peak was maximal and stable following this derivatization time. 
However, sufficient analysis of the other amino acids was also permitted following this 
procedure. 
It is important to consider the problems of instability in the amino acid levels of 
CSF. Especially GABA, glutamine, glutamic acid, and aspartic acid levels are easily 
influenced by sample handling. Therefore, in the literature, the reported levels of 
amino acids in CSF vary widely189"191. In order to be able to perform valid 
bioanalytical investigations of clinical samples, it is crucial that a strict sampling 
procedure is followed. All the samples need to be obtained in exactly the same, 
controlled way, avoiding unintentional degradation, stored at -80°C, and analysed at 
the same time, etc. 
Another problem which might influence the results is the risk of comigrating 
substances (less common in CE than in most other separation techniques, due to the 
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high peak capacity and selectivity obtained with CE) which have to be carefully 
thought about, and, if possible, excluded by changing the ionic strength or the pH in 
the separation system, or by running a second analytical method (e.g. HPLC) 
separately, in parallel, and comparing the data (see Paper III). 
Maybe the low sample consumption in CE (with only 5.9 nL injection volume), 
does not fully realize its potential in this application, since CSF samples often are of 
rather large volume (12 mL from adults and ~3 mL from children under the age of 16). 
However, the consumption of expensive derivatizing agents is kept low in CE. As a 
comparison, a conventional HPLC method for GABA analysis in CSF consumes 
192 
approximately 2.5 (iL of sample and 25 (iL of reagents (OPA, 10 mg/mL) . 
The results from the analysis of CSF from Alzheimer's patients and children with 
neurological disorders must be seen as preliminary. In order to be able to interpret 
anything definite about the differences between patients and controls individual 
samples in larger numbers need to be investigated. Preferably consecutive samples, 
from the same patient, are drawn over a period of time in order to evaluate the 
individual fluctuations. Notable, is the recent study of CSF from leukaemic children 
by Nouadje et al. (1995)26, where basically the same method for separation and 
detection of primary amines and amino acids as shown in this thesis, was used. The 
only difference was the derivatizing agent (FITC instead of CBQCA), and the lack of 
an internal standard to control the reaction equilibrium and the injected amount of 
material in their system. There was good agreement of their results with ours, except 
for aspartic acid. Nouadje et al.26 found 10 times higher levels of aspartic acid. The 
reason for this discrepancy is not obvious. However, their congruent data strengthens 
our findings and based on this and a number of other recent reports of clinical 
applications of CE193' 194, it is our belief that CE might become a powerful tool in 
clinical laboratories in the near future. 
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In the second paper we showed that proteins specific for CNS may be analyzed in 
CSF after a specially designed purification scheme, including affinity- and reversed-
phase chromatography. Trace levels of the synaptic vesicle specific protein, 
synaptotagmin, can be quantitated with chemiluminescence immunoblotting, and a 
decrease of this protein has been found in CSF from patients with early onset 
Alzheimer disease patients. This data is preliminary, in view of the small number of 
patients and the fact that their CSF was pooled. However a decreased concentration is 
also present in hippocampus and frontal cortex of these patients, further supporting the 
findings in the CSF. 
Because of the high abundance of plasma proteins in CSF (-70% of the protein 
content in CSF is derived from plasma), purification procedures like the one described 
here, are of great importance, enabling the analysis of the trace level proteins derived 
from the CNS. In conjunction with the HPLC purification step, CE with UV-detection 
has been used for further characterisation and purity analysis of these proteins. The 
unique and complementary selectivity differences of CE and HPLC make them an 
ideal combination for purity cross confirmation. 
As seen in the electropherogram in Paper II, one single peak was detected in the 
HPLC fraction, supporting the presence of only one protein in that specific fraction. In 
order to increase the detection, the sample has been dissolved in low ionic strength 
solvent in order to cause sample stacking inside the capillary, and a rather long 
injection time (10 s, 59 nL) has been used. There is little reason to believe that there 
could be problems with comigration in this separation, with very high efficiency 
(>290000 calculated number of theoretical plates) for the resulting peak. 
It is not known whether the entire synaptotagmin molecule or only a N-truncated 
form of the protein is present in CSF. Since there is no synaptotagmin standard 
available we could not confirm comigration with the CE peak. The separation 
efficiency of the SDS-PAGE can only give an approximate molecular weight, and the 
isolated amount was not sufficient for mass spectrometric determination. 
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Synaptotagmin is normally anchored in the membrane167 and therefore 
ultracentrifligation was performed to investigate whether the isolated protein was 
membrane bound or soluble. Since the protein stayed in solution it might be free or 
possibly complexed with another protein, not large enough to form precipitates. 
Alzheimer's disease is characterized by a number of pathological findings. A loss 
of synapses is one of them195. The amount of synaptotagmin, being important in the 
docking of vesicles to the synaptic plasma membrane, is likely to be decreased as a 
result. It is important to find tracers that monitor synaptic function and pathology in 
vivo, in order to facilitate the early diagnosis and treatment of patients with 
neurodegenerative disorders. 
In the two following papers the microdialysis technique in combination with CE-
LIF was used to monitor changes of amino acids in the periaqueductal grey matter of 
freely moving rats. The microdialysis technique has been used in many experimental 
systems27. There are many factors to consider in these types of animal experiments, 
including probe size, type of dialysis membrane, insertion and positioning; perfusion 
buffer and rate; and animal maintenance. However this is not further discussed here. 
The analysis of microdialysis samples is often difficult due to the low amounts of most 
substances. The diffusion rates of molecules across the dialysis membrane is 
determined by the difference in their concentrations. Thus, low perfusion rate 
increases the concentration but decreases the absolute available amount obtained per 
time unit, and vice versa. It is also difficult to assess the true extracellular 
concentrations. Furthermore a sampling technique has not been available for the 
measurement of fast changes , since only the sum of the effects will be seen in the 
microdialysis sample due to a low rate constant. In most applications HPLC196 or 
• 197 198 
radioimmunoassays (RIA) ' are used for the analysis of neurotransmitters. 
199 208 However there are now several reports of the use of CE ' . 
CE may permit a more sensitive analysis, wich may in turn permit a higher 
temporal resolution, usually one of the major problems with microdialysis when 
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monitoring transmitter release. Even on-line monitoring of amino acids has been 
published205,209. 
In the first of these two papers CE-LIF was used in parallel with two different 
HPLC methods, one with electrochemical detection174 and one with fluorescence 
detection175, for the analysis of GABA and glutamic acid. The effect of potassium 
stimulation (100 mM in the perfusion fluid) on released amounts of amino acids was 
studied, with or without calcium present. The two methods gave similar results, 
especially concerning GABA release patterns. Perfusion with an elevated 
concentration of potassium resulted in an increased release of GABA but failed to 
increase glutamate levels. This may be due to the potent uptake mechanism for 
glutamate in the PAG brain region210. The time in storage of samples, the differences 
in derivatizing procedures, etc. also need to be considered as possible factors, that may 
contribute to the discrepancy between the absolute values obtained with the two 
methods. Yet the CE analysis of several amino acids is a good complement to 
conventional HPLC techniques. 
In the second of the two microdialysis studies, the sensitivity of the CE-LIF 
method is used when the basal release of GABA is analysed. In this paper, the 
microdialysis probe is used both for sampling and for local administration of morphine 
and naloxone in the periaqueductal grey matter, a brain region strongly involved in 
211213 
nociceptive functions " . It was shown that morphine decreases the basal release of 
GABA suggesting an opioid inhibition of GABA, and resulting in a disinhibition of 
descending antinociceptive pathways (see Figure 8). This effect of morphine was 
blocked by the opioid receptor antagonist naloxone214, further indicating an 
involvement of opioid receptors. 
Due to the interference of both morphine and naloxone with the electrochemical 
detection in the HPLC method, HPLC could not be used in parallel with the CE 
method. The derivatizing agent CBQCA in the CE-LIF assay does not react with 
either substance, since they lack primary amines. 
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Some changes in the derivatizing procedure were made. Firstly the internal 
standard was changed from a somatostatin fragment to histamine, a molecule normally 
157 present at very low concentrations in brain tissue . Standard histamine has a 
migration time well separated from the other major components. Histamine gives a 
single peak, instead of the two given by the somatostatin fragment, which facilitates 
data evaluation. Secondly, the derivatization time was decreased to 1 h from 2 h, and 
the separations were stopped after the GABA peak eluted, in order to shorten the 
intrasample time (from 40 to 20 min). Thirdly, by increasing the injected amount five 
times (from 6 to 30 nL), this only affected the detection limit to a minor extent (from 
0.3 to 0.4 nM). Also the error in injected amount decreased from 6% to less than 2%. 
Comparing the GABA levels obtained with the CE-LIF method in the two papers 
demonstrated some, although not dramatic, differences in the absolute levels. 
Nevertheless, they could be explained by the differences in probe positioning in the 
two experiments. As seen in the schematic drawings the probes in the second paper 
are much more centered as the result of a new insertion angle. Also there may be other 
differences occurring due to sample storage. Further analyses need to be performed in 
order to establish if the release of other amino acid transmitters is affected by the 
morphine treatment; for instance glutamate may be a good candidate. Thus, these two 
papers in combination show the great potential of CE-LIF in the analysis of 
microdialysis samples as a complement, or as an alternative to HPLC. 
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Figure 8. Schematic drawing of the periaqueductal grey matter (PAG) region. 
From this region, descending pain inhibitory pathways projects down to the nucleus 
raphe magnus (NRM) in the rostroventral medulla, which in turn contain neurons 
which project to the dorsal horn of the spinal cord. These output neurons are tonically 
inhibited by GABA interneurons (via GABAÅ-receptors), which in turn may be 
regulated by either substance P (SP) via an enkephalin (ENK) neuron, or by ß-
endorphin (B-END). In the PAG region, antinociception can be induced in a number 
of different ways. As shown in Paper IV local administration of morphine decreases 
the extracellular level of GABA, suggesting a hyperpolarising effect on the GABA 
interneurons, inhibiting the basal GABA release. 
The application of CE with electrochemical detection for detection of easily 
oxidized species is presented in P apers V-VII. These applications show that the use of 
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CE with electrochemical detection might be a tool which opens up new avenues to 
explore the interactions between the nervous and the immune systems. 
The finding of catecholamines in lymphocytes derived from the immune system 
has produced many questions. The dramatic effects that catecholamines have on 
proliferation, and at differentiation, indicate an important regulatory role of these 
substances. Since we have shown that these cells produce catecholamines, both 
autocrine and paracrine routes may exist. The possibility that catecholamines might 
induce apoptosis in lymphocytes has also been measured, and a dose-dependent effect 
on DNA damage and apoptosis marker proteins was found. 
The mechanism or mechanisms by which exogenous catecholamines affect 
different cells is still somewhat unclear. Since it is known that lymphocytes have both 
a- and ß-receptors215"219 one possible course could be a receptor mediated effect. In 
preliminary studies (unpublished results) different receptor blockers have been tested. 
However the results were unclear. The receptor antagonists appear to exert an effect of 
their own and no clear inhibitory effect on the catecholamine response could be 
demonstrated. 
The regulatory effects induced by catecholamines are also induced by L-DOPA 
(Papers VI-VII, Slominski and Goodman-Snitkoff, 1992220), where the effects are 
probably not receptor mediated. In ad dition to this, we found an uptake of exogenous 
221 222 DA by lymphocytes, possibly indicating the presence of a DA transporter ' . This 
187 
uptake can be blocked by the specific DA transport inhibitor, nomifensine , further 
supporting the transporter theory (Paper VI). Once taken up into the cell cytoplasm, 
catecholamines are degraded by monoamine oxidase (MAO) and catechol-O-
methyltransferase (COMT) if they are not protected through storage in vesicles or 
other compartments at low pH. This active storage mechanism can be blocked by 
incubation with tetrabenazine, depleting the vesicles and reducing the intracellular 
levels of catecholamines (Paper VI). 
In preliminary experiments (unpublished results) the levels of catecholamines in 
isolated and extracted human lymphocyte cell nuclei were determined with CE and 
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electrochemical detection. The amount of catecholamines was found to be just a few 
zeptomoles per nucleus. No catecholamine metabolites were detected in the nuclear 
extract. The experimental data suggest that -1-2% of the total amount of 
catecholamine may be situated inside the nuclear membrane. This finding of 
catecholamines inside the nuclear membrane in PBMC is remarkable. The risk of 
contamination from cytosolic compartments is low due to the rigorous isolation and 
purification procedure. The lack of detectable catecholamine metabolites in the 
extracts further reduces the possibility of contamination. Since both MAO and COMT, 
the two major catabolic enzymes for catecholamines (at least COMT has been found in 
223 PBMC ), are located at the outer membrane of the mitochondria or in the cytosolic 
compartment, the catecholamines inside the nuclear membrane are protected. A 
nuclear membrane transporter for catecholamines is also known to exist224 which 
further strengthens this finding of intranuclear catecholamines. The role of the 
catecholamines inside the nuclear membrane is still to be resolved, but may involve 
interaction with steroid receptors or interference with transcription. 
Other preliminary data (unpublished results) show that the levels of endogenous 
catecholamines are dependent on stimulation of human lymphocytes. The 
superantigen SEA initially increased the level of DA and then caused a decrease after 
72 h of incubation. The two mitogens, Con A and aCD3, had opposite effects on 
catecholamine levels. Con A stimulation of lymphocytes increased the DA levels, 
while aCD3 decreased both the DA and the NE levels. When repeating the same 
experiments with mice spleen cells in Paper VII, no significant changes in the levels of 
endogenous catecholamines were found. The mice cells were stimulated with Con A, 
LPS, SEA, SEB and toxic shock syndrome toxin-1. At this stage, no obvious 
explanation for these results has been found. However, this data further emphasises 
the sensitivity and complexity of neuroimmunological interactions. Immunocompetent 
cells may change their neurotransmitter content due to a variety of exogenous 
influences. All the above mentioned findings are summarised in Figure 9. 
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Figure 9. A schematic drawing of a lymphocyte, illustrating the 
neuroimmunological interactions and effects of catecholamines studied in Papers V-
VII. (1) An uptake mechanism (Papers V- VII) that can be blocked with nomifensine 
(Paper VI). (2) A storage mechanism that can be blocked with tetrabenazine (Paper 
VI). (3) An uptake and presence of intranuclear catecholamines (unpublished results). 
(4) An endogenous production of catecholamines in lymphocytes (Papers V-VII) that 
can be blocked by a-methyl-p-tyrosine (Papers V, VII). (5) Finally, an inhibitory 
effect of exogenous catecholamines was found on proliferation and differentiation, in 
combination with an induction of apoptosis (Papers V-VII). 
The regulatory effect of catecholamines on immunocompetent cells is a well 
220 225-228 
studied phenomenon, both by us (Papers V-VII) and by others ' . The systemic 
229 
concentrations of these catecholamines are rather low (~1 nM) , but may reach 
significant levels locally, i.e. in the immediate vicinity of the synapse or close to a 
sympathetic varicosity. In order to evaluate what concentrations of catecholamines 
could occur locally at a synapse, a rough calculation was performed. Typical synaptic 
230 232 
vesicles have diameters in the range from 20 to 100 nm " , (50 nm would give a 
233 
volume of 65 zeptolitre) and contain 0.05-0.5 M of catecholamines . This would 
result in -2000-20000 molecules per 50 nm vesicle. If one vesicle fuses with the 
presynaptic membrane and releases its contents into the synapse (with an approximate 
volume of 10 attolitre, calculated as a cylinder with an height of 50 nm and a diameter 
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of 500 nm), this would result in a concentration of 0.3-3 raM (Figure 10). This 
concentration could be even higher (i.e. 30 mM) if 100 vesicles were released during 
the same time period. The concentrations presented are very rough estimates, and in 
addition, re-uptake and degradation mechanisms have been ignored234. 
Vol ~ 65 zeptolitre 
Vol - lOattolitre 
Figure 10. A schematic drawing of a synapse, where vesicles stored in the 
presynaptic terminal are filled with neurotransmitters, to be released into the synapse 
when fusion with the presynaptic membrane take place, and bind to receptors on the 
postsynaptic membrane, in order to forward the signal between nerve cells. 
However, this data points out the possibility that lymphocytes could encounter 
high concentrations of catecholamines in a local environment near synapses in the 
brain or close to sympathetic varicosities. In this thesis, immunocompetent cells have 
been shown to produce and actively store catecholamines (Papers V-VII). 
Furthermore, an active uptake and storage of catecholamines in these cells has also 
been established (Paper VI). Both exogenous and possibly endogenous 
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catecholamines may suppress proliferation and differentiation of immunocompetent 
cells via the induction of apoptosis (Papers VI-VII). Together, this data suggests new 
mechanisms by which the central and peripheral nervous systems may downregulate, 
or drain, the immune system locally. 
The small volume capabilities of CE and the sensitivity of electrochemical 
detection, make this an ideal tool to study the neuroimmunological network from the 
single cell aspect. Sample handling for lymphocytes with femtoliter volume is 
relatively straightforward and detection limits for catecholamines in the order of 10"'9 
to 10"20 m oles can be achieved. Key areas of future work need to include laser-induced 
fluorescence, mass spectrometry, and perhaps immunoassay based detection schemes 
of determining molecular neuroimmune interactions. 
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8. Conclusions 
Vi vet att den mänskliga hjärnan finns där för förhindra att öronen trasslar in sig i 
varandra 
cfotyries, 
^ CE with laser-induced fluorescence detection has been shown to be a new tool in 
medical neuroscience for the sensitive analysis of neuroactive amino acids in the 
CSF. Levels of individual amino acids can be determined, indicating the potential 
of CE for the analysis of CSF as a method both, for the study of CNS disorders 
and, for the examination of the pathophysiological mechanisms underlying these 
disorders (Paper I). 
^ Proteins specific to the CNS may be analysed in the CSF according to a specially 
designed purification scheme. Trace levels of the synaptic vesicle specific protein, 
synaptotagmin, can be quantified, and a decreased content of this protein has been 
shown in the CSF of patients with early onset Alzheimer's disease. This 
phenomenon is also seen in the hippocampus and frontal cortex of these patients, 
further supporting the CSF findings. CE with UV detection is a universal method 
for studying the purity and characteristics of analytes after other separation and 
purification methods. The unique complementary selectivity differences of CE 
and HPLC make them an ideal combination for cross confirmation of purity 
(Paper II). 
CE with laser-induced fluorescence detection, has become a new analytical tool in 
neuropharmacology, for the analysis of neuroactive amino acids in microdialysis 
samples, as shown by the analysis of local fast and transient changes in animal 
cerebrum (Paper III). 
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^ CE with laser-induced fluorescence detection permits the detection of the basal 
release levels of GABA in the periaqueductal grey matter. Local administration of 
morphine in this region led to a significant decrease of the GABA level, providing 
direct experimental evidence for an opioid induced inhibition of a tonic GABA 
release, which may in turn lead to a disinhibition of the descending pain inhibitory 
pathways (Paper IV) 
^ CE with electrochemical detection permits analysis of neurotransmitters down to 
the single cell level. The technique has been shown to be instrumental in the 
discovery of a new neuroimmunological communication pathway, where 
catecholamines are endogenously produced in cells derived from the immune 
system of both human and murine origin (Papers V-VII). 
^ Catecholamines can act as autocrine and paracrine regulators of human and murine 
lymphocyte activity (Papers V-VII). 
^ An uptake mechanism for exogenous catecholamines in lymphocytes can be 
blocked by an uptake inhibitor (Paper VI) 
^ An intracellular storage mechanism for catecholamines in lymphocytes can be 
blocked by a storage blocker (Paper VI) 
^ Catecholamines may induce apoptosis in lymphocytes, involving changes in levels 
of apoptotic marker proteins like Bcl-2/Bax and Fas/FasL, indicating a possible 
regulatory mechanism for the nervous system to suppress the immune system 
locally (Papers VI-VII). 
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9. Summary in lay language (Svensk sammanfattning) 
Den medicinska forskningen har gjort sådana enorma framsteg att det praktiskt taget 
inte finns några friska människor längre 
~Ä/c/ous< fflûadey 
En viktig uppgift inom modern neurovetenskap, är att finna metoder för att kunna 
detektera och kvantifiera specifika molekyler, som reflekterar cellkommunikationen. 
Denna signalering pågår ständigt inom cellen, mellan celler inom nervsystemet, mellan 
nervsystemet och andra system och organ i kroppen. 
Frågeställning: 
Kan kapillärelektroforetiska tekniker tillämpas för att studera förändringar i nivåer 
av olika neurotransmittorer och proteiner, i enskilda celler och kroppsvätskor? 
für Kan dessa förändringar vara tidiga markörer för ett progredierande 
sjukdomsförlopp i CNS, som i förlängningen kan komma att leda till psykisk 
störning eller demens? 
ty7 Kan kopplingen mellan immun- och nervsystemet vara en viktig faktor i en rubbad 
biologisk jämvikt som uppträder vid ovan nämnda störningar? 
f/7 Kan en katekolamin inducerad apoptos vara en del av orsaken till a tt det centrala 
nervsystemet är immunologiskt privilegierat? 
Metodik: 
Vi har konstruerat och utvecklat ett eget kapillärelektrofores (CE) instrument, som 
parallellt med ett kommersiellt instrument, har använts för neurokemiska analyser av 
substanser i biologiska system. Denna relativt nya analytiska teknik utvecklades i 
slutet av 1980-talet, mer än 20 år efter genombrottet för högtrycks vätskekromatografi 
(HPLC). Kapillär elektrofores tekniken erbjuder flertalet olika system för snabba och 
effektiva separationer av alla möjliga molekyler, ifrån metalljoner till stora 
makromolekyler. Metoden tillåter provtagning från mycket små volymer (enstaka 
celler och subcellulära fraktioner), ger utsökt upplösning med upp till en miljon 
teoretiska bottnar, samt har mycket god känslighet (ner till enstaka molekyler). Alla 
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dessa egenskaper är av stor vikt vid studier av komplexa samband inom neurobiologin 
och neurokemin. Förutom CE har en rad b iokemiska analys metoder använts (ELISA, 
ELISPOT, HPLC, flödescytometri, western blot). 
Våra försök har utförts dels direkt på cerebrospinal vätska (CSF), på enskild cell 
nivå vid analys av lymfocyter, dels på extraherade perifera cellpopulationer av humant 
och murint ursprung, samt på mikrodialysat från hjärnregioner hos råtta. 
Resultat och slutsatser: 
^ Genom att använda CE med laser-inducerad fluorescens detektion har vi 
analyserat ett flertal neurobiologiskt aktiva amino syror i mycket små provvolymer 
(6 nL injicerad volym). Denna metodik har visat sig vara användbar vid 
undersökningar av amino syra nivåer i CSF vid t.ex. neurodegenerativa sjukdomar. 
^ Genom att använda UV detektion, har kapillärelektrofores tekniken kunnat bidraga 
till fyndet av ett hjärnspecifikt protein i human CSF, synaptotagmin. Detta 
synapsvesikel protein kan komma att utgöra en tidig markör för neuronal skada 
och synapsförlust. Sänkta nivåer av proteinet konstaterades i CSF och 
hjärnvävnad från Alzheimer's patienter. 
& I två neurofarkamotogiska studier, fann vi att CE lämpar sig väl som metod för 
analys av snabba förändringar av frisatt mängd amino syror i specifika 
hjärnregioner. Detta ledde till fyndet av en verkningsmekanism för morfins 
smärtinhibitoriska funktion i den periaqueductala grå substansen. 
^ Genom att använda elektrokemisk detektion och CE, är vi först med att ha studerat 
katekolaminers produktion och lagring i immunkompetenta celler. Vidare har vi 
funnit belägg för att katekolaminer påverkar proliferation och differentiering hos 
dessa celler. Detta kan förklaras av en induktion av apoptos, som involverar Bcl-
2/Bax och Fas/FasL. Detta innebär en ny väg för nervsystemet att påverka 
immunsystemet och vice versa. Resultaten antyder även i förlängningen nya 
patofysiologiska mekanismer vid neurodegenerativa sjukdomar. 
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